Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gata5
|
ENSMUSG00000015627.5 | GATA binding protein 5 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_180353422_180353582 | Gata5 | 18803 | 0.109786 | -0.55 | 1.2e-05 | Click! |
chr2_180343401_180343579 | Gata5 | 8791 | 0.124755 | 0.37 | 6.0e-03 | Click! |
chr2_180343203_180343361 | Gata5 | 8583 | 0.125172 | 0.33 | 1.4e-02 | Click! |
chr2_180347153_180347410 | Gata5 | 12582 | 0.118687 | -0.32 | 1.8e-02 | Click! |
chr2_180359176_180359337 | Gata5 | 24557 | 0.100766 | -0.29 | 3.0e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr18_34519493_34519793 | 103.54 |
n-R5s24 |
nuclear encoded rRNA 5S 24 |
9906 |
0.14 |
chr19_46905504_46905664 | 92.77 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
3991 |
0.2 |
chr2_84938621_84938923 | 90.11 |
Slc43a3 |
solute carrier family 43, member 3 |
1882 |
0.24 |
chr9_67877471_67877811 | 78.17 |
Vps13c |
vacuolar protein sorting 13C |
37229 |
0.16 |
chr9_113969020_113969322 | 76.68 |
Ubp1 |
upstream binding protein 1 |
54 |
0.97 |
chr8_122321694_122322027 | 75.64 |
Zfpm1 |
zinc finger protein, multitype 1 |
11838 |
0.12 |
chr7_100466963_100467472 | 75.14 |
Gm10603 |
predicted gene 10603 |
27 |
0.95 |
chr12_32122969_32123242 | 72.37 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
597 |
0.75 |
chr11_61075462_61075620 | 71.72 |
Kcnj12 |
potassium inwardly-rectifying channel, subfamily J, member 12 |
9737 |
0.17 |
chr18_32542304_32542816 | 71.05 |
Gypc |
glycophorin C |
7142 |
0.21 |
chr13_119232480_119232644 | 70.95 |
Gm44488 |
predicted gene, 44488 |
37042 |
0.17 |
chr5_139803949_139804524 | 66.91 |
Tmem184a |
transmembrane protein 184a |
3744 |
0.14 |
chr13_74071260_74071584 | 64.96 |
Cep72 |
centrosomal protein 72 |
9123 |
0.15 |
chr2_62618927_62619093 | 64.65 |
Ifih1 |
interferon induced with helicase C domain 1 |
20463 |
0.17 |
chr4_41082921_41083078 | 63.02 |
Aqp3 |
aquaporin 3 |
11449 |
0.11 |
chr7_80542454_80542814 | 62.76 |
Blm |
Bloom syndrome, RecQ like helicase |
7515 |
0.17 |
chr18_56871580_56871757 | 62.65 |
Gm18087 |
predicted gene, 18087 |
44420 |
0.14 |
chr4_154911733_154912047 | 61.88 |
Prxl2b |
peroxiredoxin like 2B |
12755 |
0.11 |
chr3_100483030_100483202 | 60.81 |
Tent5c |
terminal nucleotidyltransferase 5C |
6078 |
0.15 |
chr5_142638000_142638229 | 60.62 |
Wipi2 |
WD repeat domain, phosphoinositide interacting 2 |
8521 |
0.16 |
chr19_40536565_40536862 | 60.19 |
Aldh18a1 |
aldehyde dehydrogenase 18 family, member A1 |
18028 |
0.13 |
chr19_5967617_5967939 | 60.16 |
Pola2 |
polymerase (DNA directed), alpha 2 |
3576 |
0.1 |
chr4_154023722_154024341 | 60.12 |
Smim1 |
small integral membrane protein 1 |
292 |
0.82 |
chr11_102895930_102896093 | 59.56 |
Gfap |
glial fibrillary acidic protein |
1120 |
0.32 |
chr1_75160023_75160186 | 59.41 |
Zfand2b |
zinc finger, AN1 type domain 2B |
8542 |
0.07 |
chr5_22557624_22557806 | 58.81 |
6030443J06Rik |
RIKEN cDNA 6030443J06 gene |
3800 |
0.14 |
chr19_31781133_31781545 | 58.67 |
Prkg1 |
protein kinase, cGMP-dependent, type I |
16306 |
0.26 |
chr7_56015254_56015435 | 58.58 |
Rps12l1 |
ribosomal protein S12-like 1 |
1328 |
0.25 |
chr10_3993751_3994053 | 57.55 |
Gm16074 |
predicted gene 16074 |
1531 |
0.36 |
chr19_5268996_5269230 | 56.81 |
Pacs1 |
phosphofurin acidic cluster sorting protein 1 |
3594 |
0.1 |
chr2_71073920_71074109 | 56.22 |
Dcaf17 |
DDB1 and CUL4 associated factor 17 |
1328 |
0.46 |
chr7_133698079_133698264 | 56.19 |
Uros |
uroporphyrinogen III synthase |
91 |
0.95 |
chr7_75350230_75350533 | 56.12 |
Gm10161 |
predicted pseudogene 10161 |
15674 |
0.18 |
chr2_84811935_84812131 | 55.66 |
Ube2l6 |
ubiquitin-conjugating enzyme E2L 6 |
5804 |
0.11 |
chr12_12488288_12488471 | 55.63 |
4921511I17Rik |
RIKEN cDNA 4921511I17 gene |
95764 |
0.08 |
chr18_82634085_82634259 | 55.49 |
Zfp236 |
zinc finger protein 236 |
6045 |
0.15 |
chr4_93583749_93583913 | 55.31 |
Gm12640 |
predicted gene 12640 |
15355 |
0.19 |
chr3_66486294_66486454 | 55.19 |
Gm17952 |
predicted gene, 17952 |
77177 |
0.1 |
chr5_50126295_50126569 | 54.74 |
4930448I18Rik |
RIKEN cDNA 4930448I18 gene |
24901 |
0.19 |
chr13_59795759_59796072 | 54.74 |
Tut7 |
terminal uridylyl transferase 7 |
1215 |
0.28 |
chr10_86352578_86352854 | 54.66 |
Timp3 |
tissue inhibitor of metalloproteinase 3 |
49862 |
0.12 |
chr1_77281437_77282151 | 54.66 |
Epha4 |
Eph receptor A4 |
95813 |
0.08 |
chr3_144683250_144683425 | 54.55 |
Sh3glb1 |
SH3-domain GRB2-like B1 (endophilin) |
14130 |
0.15 |
chr10_93143358_93143676 | 54.16 |
Cdk17 |
cyclin-dependent kinase 17 |
17358 |
0.17 |
chr13_23596067_23596263 | 54.09 |
H4c4 |
H4 clustered histone 4 |
14567 |
0.04 |
chr7_133552409_133552576 | 53.87 |
Tex36 |
testis expressed 36 |
49666 |
0.11 |
chr14_47240707_47240883 | 53.43 |
Wdhd1 |
WD repeat and HMG-box DNA binding protein 1 |
4475 |
0.11 |
chr18_62166142_62166444 | 53.41 |
Adrb2 |
adrenergic receptor, beta 2 |
13666 |
0.18 |
chr2_69816530_69817015 | 53.10 |
Klhl23 |
kelch-like 23 |
5172 |
0.12 |
chr13_93381331_93381617 | 52.78 |
Gm47155 |
predicted gene, 47155 |
29309 |
0.13 |
chr11_109557350_109557676 | 52.76 |
Arsg |
arylsulfatase G |
13759 |
0.16 |
chr10_98906099_98906275 | 52.29 |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
8219 |
0.28 |
chr5_146693002_146693297 | 52.20 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
13473 |
0.17 |
chr6_117888847_117889126 | 52.11 |
Gm29509 |
predicted gene 29509 |
10215 |
0.11 |
chr14_34623503_34623789 | 52.04 |
Opn4 |
opsin 4 (melanopsin) |
23504 |
0.11 |
chr11_86742694_86743016 | 51.82 |
Cltc |
clathrin, heavy polypeptide (Hc) |
14646 |
0.18 |
chr7_84723275_84723431 | 51.61 |
2610206C17Rik |
RIKEN cDNA 2610206C17 gene |
29774 |
0.14 |
chr16_90964377_90964677 | 51.36 |
Synj1 |
synaptojanin 1 |
4818 |
0.11 |
chr1_180148615_180148897 | 51.36 |
Gm38331 |
predicted gene, 38331 |
605 |
0.7 |
chr9_106398771_106398931 | 51.15 |
Dusp7 |
dual specificity phosphatase 7 |
24232 |
0.09 |
chr7_103809554_103809721 | 51.06 |
Hbb-bt |
hemoglobin, beta adult t chain |
4359 |
0.07 |
chr18_78351325_78351617 | 50.97 |
Gm6133 |
predicted gene 6133 |
1717 |
0.5 |
chr17_83659006_83659302 | 50.88 |
Kcng3 |
potassium voltage-gated channel, subfamily G, member 3 |
27259 |
0.19 |
chr9_98314165_98314344 | 50.67 |
Gm28530 |
predicted gene 28530 |
12604 |
0.2 |
chr12_28805137_28805472 | 50.51 |
Gm48905 |
predicted gene, 48905 |
4834 |
0.19 |
chr5_121236293_121236483 | 50.16 |
Hectd4 |
HECT domain E3 ubiquitin protein ligase 4 |
16169 |
0.13 |
chr16_35807108_35807273 | 49.98 |
Gm26838 |
predicted gene, 26838 |
1756 |
0.26 |
chr5_34730389_34730540 | 49.94 |
Mir467g |
microRNA 467g |
2508 |
0.21 |
chr1_136427750_136427915 | 49.75 |
Ddx59 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 59 |
2351 |
0.24 |
chr15_36338833_36339076 | 49.49 |
Gm33936 |
predicted gene, 33936 |
10800 |
0.13 |
chr9_64590624_64590805 | 49.26 |
Megf11 |
multiple EGF-like-domains 11 |
43815 |
0.17 |
chr11_31843822_31844223 | 49.16 |
Gm12107 |
predicted gene 12107 |
11362 |
0.18 |
chr18_67670424_67670597 | 48.53 |
Ptpn2 |
protein tyrosine phosphatase, non-receptor type 2 |
19714 |
0.14 |
chr16_21791898_21792066 | 48.43 |
1300002E11Rik |
RIKEN cDNA 1300002E11 gene |
2336 |
0.18 |
chr11_102363647_102363997 | 48.33 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
118 |
0.93 |
chr1_193001497_193001909 | 48.31 |
Syt14 |
synaptotagmin XIV |
33941 |
0.13 |
chr1_23417664_23417842 | 48.07 |
Ogfrl1 |
opioid growth factor receptor-like 1 |
19981 |
0.19 |
chr7_133702434_133702737 | 47.93 |
Uros |
uroporphyrinogen III synthase |
31 |
0.96 |
chr16_56801807_56801992 | 47.86 |
Adgrg7 |
adhesion G protein-coupled receptor G7 |
6044 |
0.19 |
chr7_133563294_133563459 | 47.74 |
Tex36 |
testis expressed 36 |
38782 |
0.12 |
chr16_32509635_32510013 | 47.66 |
Zdhhc19 |
zinc finger, DHHC domain containing 19 |
10213 |
0.13 |
chr2_131205772_131206168 | 47.61 |
Ap5s1 |
adaptor-related protein 5 complex, sigma 1 subunit |
1108 |
0.33 |
chr4_42880247_42880414 | 47.52 |
Fam205c |
family with sequence similarity 205, member C |
6096 |
0.14 |
chr11_64843201_64843493 | 47.49 |
Gm12292 |
predicted gene 12292 |
406 |
0.9 |
chr9_119469764_119470364 | 47.48 |
Exog |
endo/exonuclease (5'-3'), endonuclease G-like |
25077 |
0.13 |
chr10_98907006_98907267 | 47.38 |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
7270 |
0.28 |
chr11_85804098_85804434 | 47.18 |
2610027K06Rik |
RIKEN cDNA 2610027K06 gene |
111 |
0.94 |
chr9_123981971_123982159 | 47.06 |
Ccr1l1 |
chemokine (C-C motif) receptor 1-like 1 |
3657 |
0.21 |
chr15_35723507_35723790 | 46.92 |
Gm18994 |
predicted gene, 18994 |
9956 |
0.19 |
chr2_34783047_34783388 | 46.83 |
Hspa5 |
heat shock protein 5 |
8370 |
0.12 |
chr15_36360826_36360990 | 46.57 |
Gm33936 |
predicted gene, 33936 |
6199 |
0.14 |
chr8_13202926_13203099 | 46.52 |
2810030D12Rik |
RIKEN cDNA 2810030D12 gene |
2192 |
0.16 |
chr6_137317562_137317841 | 46.38 |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
65236 |
0.12 |
chr13_32234058_32234360 | 46.36 |
Gmds |
GDP-mannose 4, 6-dehydratase |
6968 |
0.28 |
chr17_5507162_5507322 | 46.33 |
Zdhhc14 |
zinc finger, DHHC domain containing 14 |
14685 |
0.18 |
chr17_88459635_88459801 | 46.32 |
Foxn2 |
forkhead box N2 |
18943 |
0.18 |
chr8_117766047_117766202 | 46.27 |
Gm31774 |
predicted gene, 31774 |
17864 |
0.14 |
chr9_66182054_66182393 | 46.21 |
Dapk2 |
death-associated protein kinase 2 |
23988 |
0.17 |
chr13_3866502_3866681 | 45.95 |
Calm5 |
calmodulin 5 |
12323 |
0.11 |
chr10_75706088_75706403 | 45.88 |
Cabin1 |
calcineurin binding protein 1 |
5870 |
0.14 |
chr17_40810907_40811196 | 45.67 |
Rhag |
Rhesus blood group-associated A glycoprotein |
75 |
0.96 |
chr13_59814367_59814542 | 45.56 |
Tut7 |
terminal uridylyl transferase 7 |
4948 |
0.12 |
chr2_131135878_131136079 | 45.48 |
Gm11037 |
predicted gene 11037 |
2481 |
0.15 |
chr3_87901211_87901576 | 45.46 |
Hdgf |
heparin binding growth factor |
4928 |
0.11 |
chr17_84926246_84926536 | 44.94 |
Gm49982 |
predicted gene, 49982 |
23822 |
0.14 |
chr11_32296147_32296690 | 44.91 |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
71 |
0.95 |
chrX_164164755_164165040 | 44.91 |
Ace2 |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
2719 |
0.26 |
chr7_78799835_78799993 | 44.83 |
Mrpl46 |
mitochondrial ribosomal protein L46 |
16383 |
0.1 |
chr11_30166306_30166594 | 44.71 |
Sptbn1 |
spectrin beta, non-erythrocytic 1 |
31807 |
0.19 |
chr11_5573962_5574135 | 44.66 |
Ankrd36 |
ankyrin repeat domain 36 |
35 |
0.97 |
chr6_3565742_3566012 | 44.60 |
Vps50 |
VPS50 EARP/GARPII complex subunit |
4817 |
0.22 |
chr19_46849397_46849711 | 44.59 |
Cnnm2 |
cyclin M2 |
16106 |
0.17 |
chr11_105366062_105366358 | 44.39 |
Gm11638 |
predicted gene 11638 |
2958 |
0.23 |
chr11_32283463_32283827 | 44.06 |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
134 |
0.92 |
chr4_124774499_124774795 | 43.90 |
Inpp5b |
inositol polyphosphate-5-phosphatase B |
5319 |
0.1 |
chrX_42019468_42019889 | 43.82 |
Xiap |
X-linked inhibitor of apoptosis |
40001 |
0.15 |
chr10_43594282_43594458 | 43.72 |
F930017D23Rik |
RIKEN cDNA F930017D23 gene |
931 |
0.48 |
chr3_117440417_117440724 | 43.53 |
Plppr5 |
phospholipid phosphatase related 5 |
44514 |
0.16 |
chr9_54704347_54704689 | 43.53 |
Mir5710 |
microRNA 5710 |
3795 |
0.15 |
chr11_45805281_45805840 | 43.30 |
F630206G17Rik |
RIKEN cDNA F630206G17 gene |
2527 |
0.22 |
chr15_73743137_73743355 | 43.27 |
Ptp4a3 |
protein tyrosine phosphatase 4a3 |
4388 |
0.19 |
chr3_60819645_60819924 | 43.26 |
Gm38326 |
predicted gene, 38326 |
31423 |
0.15 |
chr6_35256783_35257063 | 42.84 |
1810058I24Rik |
RIKEN cDNA 1810058I24 gene |
4191 |
0.18 |
chr2_122036195_122036448 | 42.75 |
Eif3j1 |
eukaryotic translation initiation factor 3, subunit J1 |
7669 |
0.16 |
chr7_135721480_135721641 | 42.64 |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
5199 |
0.18 |
chr11_65650060_65650234 | 42.36 |
Gm26128 |
predicted gene, 26128 |
23753 |
0.21 |
chr7_120969343_120969499 | 42.30 |
Cdr2 |
cerebellar degeneration-related 2 |
12369 |
0.1 |
chr14_75138507_75138871 | 42.28 |
Gm15628 |
predicted gene 15628 |
1777 |
0.27 |
chr5_73191818_73192155 | 42.26 |
Fryl |
FRY like transcription coactivator |
107 |
0.94 |
chr11_90727394_90727734 | 42.20 |
Tom1l1 |
target of myb1-like 1 (chicken) |
39198 |
0.15 |
chr16_76456094_76456254 | 42.11 |
Gm45030 |
predicted gene 45030 |
46735 |
0.13 |
chr18_50028238_50028565 | 42.06 |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
2617 |
0.3 |
chr18_62174603_62175149 | 42.04 |
Adrb2 |
adrenergic receptor, beta 2 |
5083 |
0.21 |
chr6_87775979_87776163 | 42.00 |
Gm43904 |
predicted gene, 43904 |
72 |
0.92 |
chr12_105824762_105825098 | 41.91 |
Papola |
poly (A) polymerase alpha |
4137 |
0.21 |
chr1_184645271_184645605 | 41.86 |
Gm37800 |
predicted gene, 37800 |
15965 |
0.15 |
chr15_91252133_91252292 | 41.85 |
CN725425 |
cDNA sequence CN725425 |
20634 |
0.22 |
chr15_62223170_62223510 | 41.68 |
Pvt1 |
Pvt1 oncogene |
737 |
0.72 |
chr8_123978851_123979300 | 41.67 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
4047 |
0.12 |
chr4_116101048_116101361 | 41.67 |
Rad54l |
RAD54 like (S. cerevisiae) |
1146 |
0.32 |
chr19_25055203_25055363 | 41.54 |
Dock8 |
dedicator of cytokinesis 8 |
2670 |
0.33 |
chr11_83286668_83286957 | 41.46 |
Slfn14 |
schlafen 14 |
86 |
0.93 |
chr5_146703717_146704190 | 41.40 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
2669 |
0.26 |
chr14_36618544_36618727 | 41.38 |
Gm17940 |
predicted gene, 17940 |
643 |
0.77 |
chr11_87358280_87359463 | 41.37 |
Ppm1e |
protein phosphatase 1E (PP2C domain containing) |
152 |
0.93 |
chr18_64485762_64485936 | 41.30 |
Fech |
ferrochelatase |
3092 |
0.21 |
chr10_61123577_61123747 | 41.27 |
Gm44308 |
predicted gene, 44308 |
1573 |
0.32 |
chr4_120630429_120630582 | 41.17 |
Gm12860 |
predicted gene 12860 |
14665 |
0.13 |
chr3_144670267_144670456 | 41.17 |
Sh3glb1 |
SH3-domain GRB2-like B1 (endophilin) |
27106 |
0.13 |
chr13_91540451_91540746 | 41.05 |
Ssbp2 |
single-stranded DNA binding protein 2 |
1255 |
0.59 |
chr19_24517179_24517341 | 41.01 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
38529 |
0.14 |
chr7_127626544_127626702 | 41.00 |
Zfp629 |
zinc finger protein 629 |
10826 |
0.07 |
chr2_126165605_126165911 | 40.89 |
Dtwd1 |
DTW domain containing 1 |
11217 |
0.19 |
chr12_57184479_57184693 | 40.72 |
Slc25a21 |
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21 |
12886 |
0.21 |
chr6_87184550_87184718 | 40.69 |
Gm44416 |
predicted gene, 44416 |
10625 |
0.16 |
chr10_80553553_80553870 | 40.65 |
Rexo1 |
REX1, RNA exonuclease 1 |
4249 |
0.1 |
chr1_132026947_132027256 | 40.57 |
Mfsd4a |
major facilitator superfamily domain containing 4A |
1932 |
0.25 |
chr11_46077835_46078001 | 40.52 |
Adam19 |
a disintegrin and metallopeptidase domain 19 (meltrin beta) |
21860 |
0.11 |
chr7_48992340_48992500 | 40.49 |
Nav2 |
neuron navigator 2 |
33323 |
0.14 |
chr2_160619427_160619728 | 40.45 |
Gm14221 |
predicted gene 14221 |
394 |
0.83 |
chr17_35104821_35105105 | 40.39 |
Ly6g5c |
lymphocyte antigen 6 complex, locus G5C |
3316 |
0.06 |
chr1_131126323_131126498 | 40.35 |
Dyrk3 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
11835 |
0.13 |
chr6_41704227_41704508 | 40.34 |
Kel |
Kell blood group |
28 |
0.96 |
chr1_77298700_77298868 | 40.27 |
Epha4 |
Eph receptor A4 |
78823 |
0.11 |
chr4_134869469_134869641 | 40.20 |
Rhd |
Rh blood group, D antigen |
5019 |
0.18 |
chrX_162470321_162470491 | 40.16 |
Reps2 |
RALBP1 associated Eps domain containing protein 2 |
82173 |
0.08 |
chr1_178712677_178713031 | 40.11 |
Gm34176 |
predicted gene, 34176 |
42954 |
0.17 |
chr5_5189769_5189922 | 40.02 |
Cdk14 |
cyclin-dependent kinase 14 |
5510 |
0.19 |
chr8_94169681_94169849 | 39.96 |
Mt2 |
metallothionein 2 |
2899 |
0.13 |
chr13_95671451_95671789 | 39.96 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
101 |
0.96 |
chr1_154033942_154034127 | 39.79 |
Gm28286 |
predicted gene 28286 |
267 |
0.91 |
chr13_4233586_4233793 | 39.76 |
Akr1c19 |
aldo-keto reductase family 1, member C19 |
51 |
0.97 |
chr4_59247588_59247854 | 39.75 |
Gm12596 |
predicted gene 12596 |
12330 |
0.18 |
chr18_67436617_67436802 | 39.66 |
Afg3l2 |
AFG3-like AAA ATPase 2 |
761 |
0.59 |
chr13_95679618_95679929 | 39.66 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
2551 |
0.2 |
chr2_6263938_6264314 | 39.65 |
Gm13383 |
predicted gene 13383 |
6860 |
0.19 |
chr11_77752649_77752804 | 39.60 |
Gm11191 |
predicted gene 11191 |
5685 |
0.14 |
chr11_64841239_64841406 | 39.60 |
Gm12292 |
predicted gene 12292 |
2431 |
0.39 |
chr17_46885958_46886541 | 39.54 |
Tbcc |
tubulin-specific chaperone C |
4435 |
0.17 |
chr1_175082198_175082364 | 39.42 |
Rgs7 |
regulator of G protein signaling 7 |
2856 |
0.4 |
chr13_34828020_34828310 | 39.40 |
Gm47157 |
predicted gene, 47157 |
13621 |
0.13 |
chr4_118079198_118079529 | 39.39 |
St3gal3 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 |
47481 |
0.11 |
chr1_181334651_181334972 | 39.26 |
Cnih3 |
cornichon family AMPA receptor auxiliary protein 3 |
17817 |
0.15 |
chr8_119918152_119918328 | 39.20 |
Usp10 |
ubiquitin specific peptidase 10 |
7383 |
0.17 |
chr12_84204018_84204228 | 39.19 |
Gm31513 |
predicted gene, 31513 |
8154 |
0.11 |
chr2_156882712_156882905 | 39.17 |
Sla2 |
Src-like-adaptor 2 |
4270 |
0.09 |
chr13_45130524_45130902 | 39.14 |
Gm40932 |
predicted gene, 40932 |
23820 |
0.16 |
chr2_166703530_166703689 | 38.98 |
Prex1 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
15 |
0.98 |
chr3_102144465_102144767 | 38.94 |
Casq2 |
calsequestrin 2 |
565 |
0.68 |
chr13_11836757_11837070 | 38.84 |
Ryr2 |
ryanodine receptor 2, cardiac |
7259 |
0.24 |
chr10_62344446_62344629 | 38.77 |
Hk1 |
hexokinase 1 |
1815 |
0.29 |
chr12_17538168_17538341 | 38.75 |
Odc1 |
ornithine decarboxylase, structural 1 |
6540 |
0.15 |
chr1_185472414_185472709 | 38.75 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
14733 |
0.12 |
chr5_96919251_96919574 | 38.75 |
Gm8013 |
predicted gene 8013 |
1860 |
0.18 |
chr1_170610404_170610568 | 38.64 |
Gm7299 |
predicted gene 7299 |
20435 |
0.16 |
chr7_103860558_103860730 | 38.54 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
7428 |
0.06 |
chr12_88984947_88985118 | 38.53 |
Nrxn3 |
neurexin III |
31633 |
0.23 |
chr1_136014984_136015150 | 38.53 |
Tmem9 |
transmembrane protein 9 |
2900 |
0.18 |
chr6_28233126_28233283 | 38.51 |
Gm42548 |
predicted gene 42548 |
3809 |
0.17 |
chr14_103086248_103086411 | 38.51 |
Fbxl3 |
F-box and leucine-rich repeat protein 3 |
3488 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
34.4 | 34.4 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
25.5 | 76.5 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
18.6 | 93.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
17.3 | 86.5 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
15.8 | 15.8 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
15.7 | 62.8 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
15.0 | 74.8 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
14.8 | 74.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
14.8 | 73.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
14.6 | 43.7 | GO:0040031 | snRNA modification(GO:0040031) |
14.2 | 56.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
13.5 | 40.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
13.3 | 39.9 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
13.0 | 39.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
12.3 | 73.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
11.4 | 11.4 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
11.2 | 33.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
10.9 | 10.9 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
10.8 | 32.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
10.7 | 32.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
10.6 | 21.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
10.6 | 211.4 | GO:0006783 | heme biosynthetic process(GO:0006783) |
10.5 | 31.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
10.2 | 40.8 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
10.1 | 30.4 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
10.1 | 241.8 | GO:0048821 | erythrocyte development(GO:0048821) |
10.0 | 40.1 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
10.0 | 20.0 | GO:0003213 | cardiac right atrium morphogenesis(GO:0003213) |
10.0 | 20.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
9.6 | 28.8 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
9.5 | 47.6 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
9.4 | 37.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
9.4 | 84.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
9.3 | 18.6 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
9.2 | 36.6 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
9.1 | 27.4 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
9.1 | 100.3 | GO:0009437 | carnitine metabolic process(GO:0009437) |
9.1 | 36.3 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
9.0 | 27.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
9.0 | 17.9 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
8.9 | 26.8 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
8.9 | 35.6 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
8.9 | 26.6 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
8.7 | 26.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
8.5 | 42.6 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
8.5 | 42.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
8.4 | 25.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
8.3 | 33.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
8.3 | 8.3 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
8.1 | 16.2 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
8.1 | 32.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
8.0 | 8.0 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
7.9 | 39.4 | GO:1901525 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
7.7 | 7.7 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
7.6 | 30.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
7.6 | 30.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
7.6 | 37.8 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
7.5 | 59.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
7.5 | 22.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
7.4 | 29.7 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
7.3 | 21.9 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
7.3 | 51.1 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
7.3 | 36.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
7.3 | 36.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
7.3 | 50.9 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
7.1 | 49.6 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
7.0 | 7.0 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
6.9 | 20.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
6.9 | 27.5 | GO:0008228 | opsonization(GO:0008228) |
6.8 | 27.4 | GO:0070836 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
6.7 | 74.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
6.7 | 33.7 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
6.7 | 26.9 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
6.7 | 33.4 | GO:1901660 | calcium ion export(GO:1901660) |
6.7 | 26.7 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
6.6 | 19.7 | GO:0061511 | centriole elongation(GO:0061511) |
6.6 | 26.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
6.5 | 13.0 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
6.5 | 26.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
6.5 | 32.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
6.5 | 19.4 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
6.4 | 19.3 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
6.3 | 25.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
6.3 | 37.6 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
6.2 | 18.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
6.2 | 24.7 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
6.2 | 24.6 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
6.1 | 18.4 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
6.1 | 18.2 | GO:0021553 | olfactory nerve development(GO:0021553) |
6.0 | 18.0 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
6.0 | 24.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
6.0 | 24.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
6.0 | 24.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
6.0 | 6.0 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
5.9 | 11.8 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
5.9 | 17.6 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
5.8 | 17.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
5.8 | 29.1 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
5.8 | 17.4 | GO:0065001 | specification of axis polarity(GO:0065001) |
5.8 | 52.3 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
5.8 | 17.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
5.8 | 11.5 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
5.7 | 23.0 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
5.7 | 5.7 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
5.7 | 11.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
5.7 | 28.4 | GO:1901563 | response to camptothecin(GO:1901563) |
5.7 | 5.7 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
5.6 | 5.6 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
5.6 | 22.6 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
5.5 | 16.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
5.5 | 16.6 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
5.5 | 16.5 | GO:0000087 | mitotic M phase(GO:0000087) |
5.4 | 10.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
5.4 | 54.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
5.4 | 16.1 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
5.4 | 5.4 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
5.4 | 21.4 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
5.3 | 5.3 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
5.3 | 5.3 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
5.3 | 47.7 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
5.3 | 15.9 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
5.3 | 15.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
5.3 | 21.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
5.2 | 5.2 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
5.2 | 15.7 | GO:0036394 | amylase secretion(GO:0036394) |
5.2 | 31.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
5.2 | 5.2 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
5.0 | 20.2 | GO:1905049 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
5.0 | 15.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
5.0 | 50.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
5.0 | 15.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
5.0 | 9.9 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
5.0 | 9.9 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
4.9 | 14.7 | GO:0042117 | monocyte activation(GO:0042117) |
4.9 | 24.3 | GO:0015671 | oxygen transport(GO:0015671) |
4.8 | 9.7 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
4.8 | 9.7 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
4.8 | 14.5 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
4.8 | 9.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
4.8 | 19.1 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
4.8 | 28.6 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
4.7 | 4.7 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
4.7 | 9.5 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
4.7 | 9.3 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
4.7 | 28.0 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
4.7 | 14.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
4.7 | 9.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
4.7 | 4.7 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
4.6 | 9.3 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
4.6 | 9.3 | GO:0032898 | neurotrophin production(GO:0032898) |
4.6 | 13.9 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
4.6 | 9.3 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
4.6 | 4.6 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
4.6 | 13.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
4.6 | 82.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
4.6 | 18.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
4.6 | 27.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
4.6 | 31.9 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
4.5 | 13.6 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
4.5 | 27.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
4.5 | 4.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
4.5 | 26.9 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
4.5 | 13.4 | GO:1903416 | response to glycoside(GO:1903416) |
4.5 | 9.0 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
4.5 | 4.5 | GO:0043379 | memory T cell differentiation(GO:0043379) |
4.5 | 17.9 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
4.5 | 13.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
4.4 | 13.3 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
4.4 | 31.0 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
4.4 | 30.9 | GO:0046037 | GMP metabolic process(GO:0046037) |
4.4 | 13.2 | GO:0035973 | aggrephagy(GO:0035973) |
4.4 | 8.7 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
4.3 | 4.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
4.3 | 12.9 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
4.3 | 4.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
4.3 | 4.3 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
4.3 | 47.3 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
4.3 | 12.9 | GO:0050904 | diapedesis(GO:0050904) |
4.3 | 12.8 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
4.3 | 12.8 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
4.3 | 12.8 | GO:0070827 | chromatin maintenance(GO:0070827) |
4.3 | 21.3 | GO:2001225 | regulation of chloride transport(GO:2001225) |
4.2 | 21.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
4.2 | 8.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
4.2 | 12.6 | GO:0015705 | iodide transport(GO:0015705) |
4.2 | 4.2 | GO:0032817 | regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) |
4.2 | 16.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
4.2 | 16.6 | GO:0006591 | ornithine metabolic process(GO:0006591) |
4.1 | 12.4 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
4.1 | 20.5 | GO:0006116 | NADH oxidation(GO:0006116) |
4.1 | 4.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
4.1 | 20.5 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
4.0 | 12.1 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
4.0 | 16.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
4.0 | 12.1 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
4.0 | 4.0 | GO:0021564 | vagus nerve development(GO:0021564) |
4.0 | 27.9 | GO:0051026 | chiasma assembly(GO:0051026) |
4.0 | 20.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
4.0 | 11.9 | GO:0072319 | vesicle uncoating(GO:0072319) |
4.0 | 35.7 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
3.9 | 11.7 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
3.9 | 7.8 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
3.9 | 7.7 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
3.9 | 15.5 | GO:0015886 | heme transport(GO:0015886) |
3.9 | 15.4 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
3.9 | 11.6 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
3.8 | 11.4 | GO:0001555 | oocyte growth(GO:0001555) |
3.8 | 15.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
3.8 | 7.6 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
3.8 | 3.8 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
3.7 | 18.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
3.7 | 7.5 | GO:0002215 | defense response to nematode(GO:0002215) |
3.7 | 18.6 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
3.7 | 22.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
3.7 | 22.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
3.7 | 11.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
3.7 | 22.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
3.7 | 11.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
3.6 | 14.6 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
3.6 | 51.0 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
3.6 | 21.7 | GO:0015871 | choline transport(GO:0015871) |
3.6 | 61.5 | GO:0000305 | response to oxygen radical(GO:0000305) |
3.6 | 14.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
3.6 | 14.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
3.6 | 10.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
3.6 | 14.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
3.6 | 53.9 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
3.6 | 39.4 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
3.6 | 10.7 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
3.6 | 3.6 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
3.6 | 3.6 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
3.6 | 7.1 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
3.5 | 7.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
3.5 | 7.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
3.5 | 24.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
3.5 | 24.7 | GO:0021860 | pyramidal neuron development(GO:0021860) |
3.5 | 3.5 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
3.5 | 10.5 | GO:0018343 | protein farnesylation(GO:0018343) |
3.5 | 14.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
3.5 | 49.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
3.5 | 31.5 | GO:0070269 | pyroptosis(GO:0070269) |
3.5 | 10.5 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
3.5 | 13.9 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
3.5 | 7.0 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
3.5 | 3.5 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
3.5 | 13.9 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
3.5 | 3.5 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
3.4 | 17.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
3.4 | 13.7 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
3.4 | 10.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
3.4 | 6.8 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
3.4 | 13.6 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
3.4 | 6.8 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
3.4 | 6.8 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
3.4 | 10.1 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
3.4 | 10.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
3.4 | 6.8 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
3.4 | 16.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
3.4 | 57.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
3.4 | 10.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
3.3 | 6.7 | GO:0036257 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
3.3 | 6.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
3.3 | 16.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
3.3 | 19.8 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
3.3 | 6.6 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
3.3 | 32.8 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
3.3 | 16.4 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
3.3 | 6.5 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
3.3 | 3.3 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
3.2 | 9.7 | GO:0034214 | protein hexamerization(GO:0034214) |
3.2 | 9.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
3.2 | 16.1 | GO:0009642 | response to light intensity(GO:0009642) |
3.2 | 12.8 | GO:0042420 | dopamine catabolic process(GO:0042420) |
3.2 | 35.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
3.2 | 19.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
3.2 | 38.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
3.2 | 66.9 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
3.2 | 6.4 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
3.2 | 15.9 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
3.2 | 9.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
3.2 | 3.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
3.2 | 9.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
3.2 | 15.8 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
3.1 | 69.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
3.1 | 3.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
3.1 | 3.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
3.1 | 9.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
3.1 | 9.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
3.1 | 9.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
3.1 | 12.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
3.1 | 3.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
3.1 | 6.1 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
3.1 | 12.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
3.1 | 33.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
3.1 | 42.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
3.0 | 9.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
3.0 | 3.0 | GO:0061010 | gall bladder development(GO:0061010) |
3.0 | 3.0 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
3.0 | 27.2 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
3.0 | 12.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
3.0 | 42.2 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
3.0 | 12.1 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
3.0 | 6.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
3.0 | 3.0 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
3.0 | 6.0 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
3.0 | 9.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
3.0 | 41.7 | GO:0006828 | manganese ion transport(GO:0006828) |
3.0 | 6.0 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
3.0 | 3.0 | GO:1902896 | terminal web assembly(GO:1902896) |
3.0 | 11.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
3.0 | 20.7 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
3.0 | 8.9 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
2.9 | 14.7 | GO:0043173 | nucleotide salvage(GO:0043173) |
2.9 | 5.9 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
2.9 | 8.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
2.9 | 32.0 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
2.9 | 20.3 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
2.9 | 11.6 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
2.9 | 2.9 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
2.9 | 11.5 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
2.9 | 5.7 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
2.9 | 8.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
2.9 | 2.9 | GO:0060556 | vitamin D biosynthetic process(GO:0042368) regulation of vitamin D biosynthetic process(GO:0060556) |
2.9 | 25.7 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
2.9 | 11.4 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
2.8 | 2.8 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
2.8 | 2.8 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
2.8 | 2.8 | GO:0072718 | response to cisplatin(GO:0072718) |
2.8 | 14.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
2.8 | 8.5 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
2.8 | 22.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
2.8 | 36.6 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
2.8 | 8.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
2.8 | 19.6 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
2.8 | 2.8 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
2.8 | 8.4 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
2.8 | 5.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
2.8 | 5.5 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
2.8 | 8.3 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
2.8 | 11.0 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
2.8 | 11.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
2.7 | 8.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
2.7 | 2.7 | GO:0070459 | prolactin secretion(GO:0070459) |
2.7 | 5.5 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
2.7 | 13.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
2.7 | 16.3 | GO:0090009 | primitive streak formation(GO:0090009) |
2.7 | 8.2 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
2.7 | 8.1 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
2.7 | 5.4 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
2.7 | 2.7 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
2.7 | 2.7 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
2.7 | 21.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
2.7 | 24.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
2.7 | 16.2 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
2.7 | 10.8 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
2.7 | 5.4 | GO:1902075 | cellular response to salt(GO:1902075) |
2.7 | 26.8 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
2.7 | 88.3 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
2.7 | 8.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
2.7 | 18.7 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
2.7 | 16.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
2.7 | 24.0 | GO:0010039 | response to iron ion(GO:0010039) |
2.7 | 10.6 | GO:0016572 | histone phosphorylation(GO:0016572) |
2.7 | 13.3 | GO:0042168 | heme metabolic process(GO:0042168) |
2.7 | 5.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
2.7 | 13.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
2.7 | 42.4 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
2.6 | 10.6 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
2.6 | 2.6 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
2.6 | 13.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
2.6 | 18.4 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
2.6 | 10.5 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
2.6 | 23.5 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
2.6 | 5.2 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
2.6 | 10.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
2.6 | 5.2 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
2.6 | 10.4 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
2.6 | 5.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
2.6 | 10.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
2.6 | 2.6 | GO:0010182 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
2.6 | 7.7 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
2.6 | 5.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
2.6 | 7.7 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
2.5 | 58.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
2.5 | 7.6 | GO:0006083 | acetate metabolic process(GO:0006083) |
2.5 | 7.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.5 | 20.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
2.5 | 2.5 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
2.5 | 5.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
2.5 | 7.6 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
2.5 | 27.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
2.5 | 7.5 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
2.5 | 7.5 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
2.5 | 22.5 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
2.5 | 5.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
2.5 | 5.0 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
2.5 | 5.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
2.5 | 5.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
2.5 | 5.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
2.5 | 14.9 | GO:0046415 | urate metabolic process(GO:0046415) |
2.5 | 2.5 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
2.5 | 7.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
2.5 | 5.0 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
2.5 | 9.8 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
2.5 | 2.5 | GO:0070431 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
2.5 | 9.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
2.5 | 9.8 | GO:0032202 | telomere assembly(GO:0032202) |
2.5 | 14.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
2.4 | 9.8 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
2.4 | 14.7 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
2.4 | 36.7 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
2.4 | 9.8 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
2.4 | 26.9 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
2.4 | 4.9 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
2.4 | 19.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
2.4 | 4.8 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
2.4 | 7.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
2.4 | 24.0 | GO:0046686 | response to cadmium ion(GO:0046686) |
2.4 | 31.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
2.4 | 26.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
2.4 | 2.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
2.4 | 14.3 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
2.4 | 7.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
2.4 | 11.9 | GO:0034204 | lipid translocation(GO:0034204) |
2.4 | 2.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
2.4 | 42.7 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
2.4 | 9.5 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
2.4 | 7.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
2.4 | 14.2 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
2.4 | 14.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
2.4 | 7.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
2.3 | 7.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
2.3 | 2.3 | GO:0032439 | endosome localization(GO:0032439) |
2.3 | 7.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
2.3 | 30.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
2.3 | 11.7 | GO:0044351 | macropinocytosis(GO:0044351) |
2.3 | 2.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
2.3 | 4.6 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
2.3 | 2.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
2.3 | 4.6 | GO:0071865 | apoptotic process in bone marrow(GO:0071839) regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
2.3 | 11.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
2.3 | 4.6 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
2.3 | 9.3 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
2.3 | 4.6 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
2.3 | 9.2 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
2.3 | 25.2 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
2.3 | 6.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
2.3 | 13.7 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
2.3 | 34.0 | GO:0007141 | male meiosis I(GO:0007141) |
2.3 | 13.6 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
2.3 | 9.1 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
2.3 | 2.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
2.3 | 9.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
2.3 | 4.5 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
2.3 | 9.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
2.3 | 9.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
2.3 | 4.5 | GO:2000301 | negative regulation of synaptic vesicle transport(GO:1902804) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
2.3 | 22.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
2.3 | 2.3 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
2.3 | 9.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
2.2 | 13.5 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
2.2 | 11.2 | GO:0006548 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
2.2 | 4.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
2.2 | 18.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
2.2 | 4.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
2.2 | 2.2 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
2.2 | 24.6 | GO:0042574 | retinal metabolic process(GO:0042574) |
2.2 | 8.9 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
2.2 | 31.3 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
2.2 | 8.9 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
2.2 | 6.6 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
2.2 | 4.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
2.2 | 4.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
2.2 | 15.4 | GO:0042448 | progesterone metabolic process(GO:0042448) |
2.2 | 2.2 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
2.2 | 19.8 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
2.2 | 8.8 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
2.2 | 4.4 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
2.2 | 13.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
2.2 | 4.4 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
2.2 | 15.3 | GO:0033131 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
2.2 | 21.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
2.2 | 2.2 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
2.2 | 6.5 | GO:0009826 | unidimensional cell growth(GO:0009826) |
2.2 | 2.2 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
2.2 | 4.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
2.2 | 2.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
2.2 | 6.5 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
2.2 | 4.3 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
2.1 | 4.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
2.1 | 4.3 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
2.1 | 2.1 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) negative regulation by symbiont of host programmed cell death(GO:0052041) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
2.1 | 2.1 | GO:0032660 | regulation of interleukin-17 production(GO:0032660) T-helper 17 cell differentiation(GO:0072539) |
2.1 | 38.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
2.1 | 8.6 | GO:0036491 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
2.1 | 6.4 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
2.1 | 4.3 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
2.1 | 6.4 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
2.1 | 17.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
2.1 | 2.1 | GO:0002707 | negative regulation of lymphocyte mediated immunity(GO:0002707) |
2.1 | 21.3 | GO:0036336 | dendritic cell migration(GO:0036336) |
2.1 | 2.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
2.1 | 4.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
2.1 | 2.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
2.1 | 63.6 | GO:0070527 | platelet aggregation(GO:0070527) |
2.1 | 19.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
2.1 | 2.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
2.1 | 10.6 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
2.1 | 10.6 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
2.1 | 6.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
2.1 | 4.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
2.1 | 8.4 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
2.1 | 6.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
2.1 | 12.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
2.1 | 8.4 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
2.1 | 2.1 | GO:0007144 | female meiosis I(GO:0007144) |
2.1 | 27.2 | GO:0045116 | protein neddylation(GO:0045116) |
2.1 | 10.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
2.1 | 8.3 | GO:0018101 | protein citrullination(GO:0018101) |
2.1 | 8.3 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
2.1 | 6.2 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
2.1 | 6.2 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) |
2.1 | 4.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
2.1 | 4.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
2.1 | 4.1 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
2.1 | 10.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
2.1 | 4.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
2.1 | 6.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
2.1 | 4.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
2.1 | 2.1 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
2.1 | 6.2 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
2.1 | 8.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
2.1 | 2.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
2.0 | 6.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
2.0 | 6.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
2.0 | 6.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
2.0 | 10.2 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
2.0 | 2.0 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
2.0 | 8.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
2.0 | 4.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
2.0 | 6.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
2.0 | 8.1 | GO:0043584 | nose development(GO:0043584) |
2.0 | 14.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
2.0 | 20.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
2.0 | 6.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
2.0 | 14.1 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
2.0 | 8.0 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
2.0 | 12.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
2.0 | 6.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
2.0 | 16.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
2.0 | 8.0 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
2.0 | 2.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
2.0 | 6.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
2.0 | 4.0 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
2.0 | 45.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
2.0 | 11.9 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
2.0 | 2.0 | GO:1902566 | regulation of eosinophil activation(GO:1902566) |
2.0 | 5.9 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
2.0 | 17.8 | GO:0001675 | acrosome assembly(GO:0001675) |
2.0 | 17.8 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
2.0 | 46.9 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
2.0 | 7.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
2.0 | 7.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.9 | 11.7 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
1.9 | 5.8 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.9 | 17.5 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
1.9 | 7.8 | GO:0018904 | ether metabolic process(GO:0018904) |
1.9 | 1.9 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
1.9 | 7.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
1.9 | 23.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
1.9 | 3.9 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.9 | 3.9 | GO:0045346 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
1.9 | 1.9 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.9 | 9.7 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
1.9 | 7.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.9 | 5.8 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
1.9 | 7.8 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
1.9 | 5.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
1.9 | 30.9 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
1.9 | 1.9 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
1.9 | 9.6 | GO:0071569 | protein ufmylation(GO:0071569) |
1.9 | 3.8 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
1.9 | 3.8 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
1.9 | 3.8 | GO:2000848 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of corticosteroid hormone secretion(GO:2000848) |
1.9 | 15.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
1.9 | 7.6 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
1.9 | 11.4 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
1.9 | 3.8 | GO:0033227 | dsRNA transport(GO:0033227) |
1.9 | 13.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
1.9 | 5.7 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
1.9 | 13.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
1.9 | 15.2 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
1.9 | 7.6 | GO:0051031 | tRNA transport(GO:0051031) |
1.9 | 9.4 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
1.9 | 28.3 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
1.9 | 5.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
1.9 | 7.5 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
1.9 | 3.7 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.9 | 9.3 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
1.9 | 16.8 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.9 | 1.9 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.9 | 7.4 | GO:0060056 | mammary gland involution(GO:0060056) |
1.9 | 16.7 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
1.9 | 13.0 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
1.8 | 1.8 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
1.8 | 25.8 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
1.8 | 3.7 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
1.8 | 9.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
1.8 | 20.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
1.8 | 1.8 | GO:0006983 | ER overload response(GO:0006983) |
1.8 | 7.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.8 | 9.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
1.8 | 16.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
1.8 | 49.0 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
1.8 | 1.8 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
1.8 | 5.4 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
1.8 | 9.0 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
1.8 | 10.8 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.8 | 7.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
1.8 | 1.8 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
1.8 | 5.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
1.8 | 12.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
1.8 | 5.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
1.8 | 5.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.8 | 12.5 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
1.8 | 1.8 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
1.8 | 3.6 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
1.8 | 1.8 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.8 | 5.3 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
1.8 | 8.8 | GO:0009650 | UV protection(GO:0009650) |
1.8 | 1.8 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.7 | 10.5 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
1.7 | 7.0 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
1.7 | 10.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.7 | 3.5 | GO:0033194 | response to hydroperoxide(GO:0033194) |
1.7 | 3.5 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
1.7 | 15.6 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
1.7 | 1.7 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
1.7 | 6.9 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.7 | 1.7 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
1.7 | 37.8 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
1.7 | 8.6 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.7 | 5.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.7 | 29.1 | GO:0006491 | N-glycan processing(GO:0006491) |
1.7 | 17.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
1.7 | 5.1 | GO:0001842 | neural fold formation(GO:0001842) |
1.7 | 8.5 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
1.7 | 3.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.7 | 15.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.7 | 1.7 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.7 | 10.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
1.7 | 1.7 | GO:0042637 | catagen(GO:0042637) |
1.7 | 3.4 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
1.7 | 1.7 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
1.7 | 10.1 | GO:0032099 | negative regulation of appetite(GO:0032099) |
1.7 | 8.4 | GO:0033574 | response to testosterone(GO:0033574) |
1.7 | 63.7 | GO:0002181 | cytoplasmic translation(GO:0002181) |
1.7 | 1.7 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
1.7 | 3.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.7 | 6.7 | GO:0046599 | regulation of centriole replication(GO:0046599) |
1.7 | 1.7 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
1.7 | 5.0 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
1.7 | 1.7 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
1.7 | 1.7 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
1.7 | 13.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
1.7 | 3.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.7 | 3.3 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
1.6 | 3.3 | GO:0019042 | viral latency(GO:0019042) |
1.6 | 1.6 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
1.6 | 9.9 | GO:0007603 | phototransduction, visible light(GO:0007603) |
1.6 | 3.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.6 | 4.9 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.6 | 1.6 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
1.6 | 3.3 | GO:0046060 | dATP metabolic process(GO:0046060) |
1.6 | 1.6 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
1.6 | 1.6 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
1.6 | 1.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.6 | 4.9 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
1.6 | 8.1 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.6 | 8.1 | GO:0021764 | amygdala development(GO:0021764) |
1.6 | 3.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
1.6 | 3.2 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.6 | 1.6 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
1.6 | 17.7 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
1.6 | 6.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
1.6 | 4.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.6 | 4.8 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
1.6 | 1.6 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
1.6 | 11.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.6 | 8.0 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
1.6 | 4.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.6 | 3.2 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
1.6 | 28.7 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
1.6 | 3.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.6 | 14.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
1.6 | 3.2 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
1.6 | 11.1 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
1.6 | 20.6 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.6 | 1.6 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
1.6 | 11.1 | GO:0097320 | membrane tubulation(GO:0097320) |
1.6 | 58.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
1.6 | 6.3 | GO:0046464 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
1.6 | 7.9 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
1.6 | 31.5 | GO:0032456 | endocytic recycling(GO:0032456) |
1.6 | 12.6 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
1.6 | 4.7 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
1.6 | 1.6 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
1.6 | 14.0 | GO:0006734 | NADH metabolic process(GO:0006734) |
1.6 | 3.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
1.6 | 6.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.6 | 31.0 | GO:0017144 | drug metabolic process(GO:0017144) |
1.5 | 4.6 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
1.5 | 1.5 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
1.5 | 1.5 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
1.5 | 3.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
1.5 | 1.5 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
1.5 | 10.7 | GO:0051014 | actin filament severing(GO:0051014) |
1.5 | 9.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.5 | 7.7 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
1.5 | 4.6 | GO:0044838 | cell quiescence(GO:0044838) |
1.5 | 1.5 | GO:0010534 | regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
1.5 | 4.6 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
1.5 | 9.2 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
1.5 | 15.3 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.5 | 4.6 | GO:0015817 | histidine transport(GO:0015817) |
1.5 | 6.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.5 | 1.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.5 | 1.5 | GO:0032366 | intracellular sterol transport(GO:0032366) |
1.5 | 3.0 | GO:0051197 | positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
1.5 | 4.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
1.5 | 1.5 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
1.5 | 6.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
1.5 | 1.5 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
1.5 | 4.5 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
1.5 | 6.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
1.5 | 1.5 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
1.5 | 24.0 | GO:0006301 | postreplication repair(GO:0006301) |
1.5 | 6.0 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
1.5 | 1.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.5 | 14.9 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
1.5 | 3.0 | GO:0048102 | autophagic cell death(GO:0048102) |
1.5 | 1.5 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
1.5 | 3.0 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
1.5 | 14.8 | GO:0006071 | glycerol metabolic process(GO:0006071) |
1.5 | 1.5 | GO:0019627 | urea metabolic process(GO:0019627) |
1.5 | 7.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
1.5 | 5.9 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
1.5 | 2.9 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.5 | 4.4 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
1.5 | 33.8 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
1.5 | 4.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.5 | 4.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.5 | 2.9 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.5 | 2.9 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.5 | 2.9 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
1.5 | 5.8 | GO:0015802 | basic amino acid transport(GO:0015802) |
1.5 | 10.2 | GO:0034063 | stress granule assembly(GO:0034063) |
1.5 | 2.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
1.5 | 5.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.5 | 18.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
1.4 | 1.4 | GO:0031268 | pseudopodium organization(GO:0031268) |
1.4 | 5.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.4 | 7.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
1.4 | 10.1 | GO:0051304 | chromosome separation(GO:0051304) |
1.4 | 12.9 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
1.4 | 17.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.4 | 11.4 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
1.4 | 57.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
1.4 | 5.7 | GO:0070475 | rRNA base methylation(GO:0070475) |
1.4 | 5.7 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
1.4 | 9.9 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
1.4 | 2.8 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.4 | 1.4 | GO:0052205 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
1.4 | 5.7 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
1.4 | 1.4 | GO:0046174 | polyol catabolic process(GO:0046174) |
1.4 | 4.2 | GO:0010226 | response to lithium ion(GO:0010226) |
1.4 | 5.7 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
1.4 | 2.8 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
1.4 | 2.8 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
1.4 | 12.7 | GO:0031639 | plasminogen activation(GO:0031639) |
1.4 | 4.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.4 | 7.0 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
1.4 | 8.4 | GO:0032060 | bleb assembly(GO:0032060) |
1.4 | 26.5 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
1.4 | 4.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
1.4 | 1.4 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
1.4 | 2.8 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
1.4 | 1.4 | GO:0030242 | pexophagy(GO:0030242) |
1.4 | 5.5 | GO:0036233 | glycine import(GO:0036233) |
1.4 | 8.3 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
1.4 | 1.4 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.4 | 2.7 | GO:0071481 | cellular response to X-ray(GO:0071481) |
1.4 | 2.7 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
1.4 | 6.8 | GO:0046697 | decidualization(GO:0046697) |
1.4 | 1.4 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
1.4 | 5.4 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
1.3 | 2.7 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
1.3 | 2.7 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
1.3 | 1.3 | GO:0071280 | cellular response to copper ion(GO:0071280) |
1.3 | 21.4 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
1.3 | 10.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
1.3 | 2.7 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.3 | 6.7 | GO:0009249 | protein lipoylation(GO:0009249) |
1.3 | 5.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.3 | 5.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
1.3 | 1.3 | GO:0007567 | parturition(GO:0007567) |
1.3 | 2.7 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
1.3 | 5.3 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
1.3 | 6.6 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
1.3 | 10.5 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
1.3 | 10.5 | GO:0009303 | rRNA transcription(GO:0009303) |
1.3 | 5.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
1.3 | 13.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
1.3 | 3.9 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
1.3 | 2.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.3 | 2.6 | GO:1902990 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
1.3 | 1.3 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
1.3 | 3.9 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
1.3 | 6.5 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
1.3 | 1.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.3 | 3.9 | GO:0007000 | nucleolus organization(GO:0007000) |
1.3 | 18.1 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
1.3 | 12.9 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
1.3 | 1.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
1.3 | 1.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.3 | 3.8 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
1.3 | 2.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
1.3 | 10.2 | GO:0007031 | peroxisome organization(GO:0007031) |
1.3 | 14.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
1.3 | 3.8 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.3 | 3.8 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.3 | 7.7 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
1.3 | 1.3 | GO:0051985 | negative regulation of sister chromatid segregation(GO:0033046) negative regulation of chromosome segregation(GO:0051985) |
1.3 | 1.3 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.3 | 5.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
1.3 | 6.4 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
1.3 | 1.3 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
1.3 | 5.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
1.3 | 5.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
1.3 | 5.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
1.3 | 3.8 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
1.3 | 15.1 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
1.3 | 2.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
1.3 | 13.9 | GO:0071320 | cellular response to cAMP(GO:0071320) |
1.3 | 1.3 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
1.3 | 5.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.3 | 10.0 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
1.3 | 3.8 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
1.3 | 42.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
1.3 | 3.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.3 | 1.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
1.2 | 2.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
1.2 | 1.2 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
1.2 | 3.7 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
1.2 | 5.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
1.2 | 24.9 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
1.2 | 3.7 | GO:0042891 | antibiotic transport(GO:0042891) |
1.2 | 2.5 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.2 | 1.2 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
1.2 | 1.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
1.2 | 24.7 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
1.2 | 1.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
1.2 | 2.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
1.2 | 13.4 | GO:0051601 | exocyst localization(GO:0051601) |
1.2 | 6.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
1.2 | 15.8 | GO:0043171 | peptide catabolic process(GO:0043171) |
1.2 | 8.5 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
1.2 | 8.5 | GO:0030325 | adrenal gland development(GO:0030325) |
1.2 | 4.8 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
1.2 | 6.0 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
1.2 | 3.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
1.2 | 4.8 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
1.2 | 2.4 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
1.2 | 2.4 | GO:0046039 | GTP metabolic process(GO:0046039) |
1.2 | 3.6 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
1.2 | 6.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
1.2 | 1.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
1.2 | 1.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
1.2 | 1.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
1.2 | 71.0 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
1.2 | 27.6 | GO:0060323 | head morphogenesis(GO:0060323) |
1.2 | 15.6 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
1.2 | 14.3 | GO:0030488 | tRNA methylation(GO:0030488) |
1.2 | 4.8 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
1.2 | 2.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.2 | 2.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.2 | 1.2 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
1.2 | 2.4 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
1.2 | 8.3 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
1.2 | 1.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
1.2 | 2.4 | GO:0003091 | renal water homeostasis(GO:0003091) |
1.2 | 2.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.2 | 3.5 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.2 | 12.8 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
1.2 | 12.8 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
1.2 | 4.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.2 | 13.9 | GO:0000154 | rRNA modification(GO:0000154) |
1.2 | 4.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.2 | 4.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.2 | 4.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
1.2 | 15.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
1.1 | 4.6 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
1.1 | 2.3 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.1 | 1.1 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
1.1 | 4.6 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
1.1 | 6.8 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
1.1 | 8.0 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
1.1 | 9.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
1.1 | 2.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
1.1 | 1.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
1.1 | 5.6 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
1.1 | 12.4 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
1.1 | 4.5 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
1.1 | 2.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
1.1 | 3.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.1 | 2.3 | GO:0045047 | protein targeting to ER(GO:0045047) |
1.1 | 5.6 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
1.1 | 1.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.1 | 1.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.1 | 3.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
1.1 | 7.8 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
1.1 | 4.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.1 | 5.6 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
1.1 | 4.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.1 | 2.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.1 | 1.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
1.1 | 1.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
1.1 | 13.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
1.1 | 3.3 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
1.1 | 1.1 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
1.1 | 1.1 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
1.1 | 12.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
1.1 | 6.6 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
1.1 | 1.1 | GO:0010390 | histone monoubiquitination(GO:0010390) |
1.1 | 1.1 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
1.1 | 3.3 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
1.1 | 7.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.1 | 2.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
1.1 | 8.7 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
1.1 | 7.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.1 | 5.4 | GO:0016266 | O-glycan processing(GO:0016266) |
1.1 | 18.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
1.1 | 5.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
1.1 | 1.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
1.1 | 8.6 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
1.1 | 3.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.1 | 1.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
1.1 | 6.4 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
1.1 | 1.1 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
1.1 | 1.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
1.1 | 12.7 | GO:0032642 | regulation of chemokine production(GO:0032642) |
1.1 | 23.2 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
1.1 | 6.3 | GO:0039535 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039531) regulation of RIG-I signaling pathway(GO:0039535) |
1.1 | 1.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
1.1 | 1.1 | GO:0014028 | notochord formation(GO:0014028) |
1.0 | 7.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
1.0 | 4.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
1.0 | 1.0 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
1.0 | 2.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.0 | 2.1 | GO:0009445 | putrescine metabolic process(GO:0009445) |
1.0 | 2.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
1.0 | 1.0 | GO:0048844 | artery morphogenesis(GO:0048844) |
1.0 | 10.4 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
1.0 | 3.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
1.0 | 1.0 | GO:0035482 | gastric motility(GO:0035482) |
1.0 | 13.4 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
1.0 | 23.8 | GO:0016925 | protein sumoylation(GO:0016925) |
1.0 | 3.1 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
1.0 | 3.1 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
1.0 | 1.0 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
1.0 | 2.1 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
1.0 | 3.1 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) hydrogen sulfide biosynthetic process(GO:0070814) |
1.0 | 1.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.0 | 7.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
1.0 | 2.0 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.0 | 1.0 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
1.0 | 15.2 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
1.0 | 7.1 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
1.0 | 3.0 | GO:2001026 | regulation of endothelial cell chemotaxis(GO:2001026) |
1.0 | 1.0 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
1.0 | 3.0 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
1.0 | 2.0 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
1.0 | 5.0 | GO:0030224 | monocyte differentiation(GO:0030224) |
1.0 | 18.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
1.0 | 2.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.0 | 36.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
1.0 | 1.0 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
1.0 | 2.0 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
1.0 | 1.0 | GO:0070828 | heterochromatin organization(GO:0070828) |
1.0 | 1.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.0 | 15.0 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
1.0 | 9.0 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.0 | 2.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
1.0 | 16.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
1.0 | 1.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
1.0 | 11.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
1.0 | 2.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.0 | 19.6 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
1.0 | 7.8 | GO:0006414 | translational elongation(GO:0006414) |
1.0 | 3.9 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
1.0 | 1.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
1.0 | 1.9 | GO:0051029 | rRNA transport(GO:0051029) |
1.0 | 1.9 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.0 | 2.9 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
1.0 | 2.9 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
1.0 | 5.8 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
1.0 | 3.8 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
1.0 | 1.9 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
1.0 | 6.7 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
1.0 | 4.8 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
1.0 | 3.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.0 | 5.7 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
1.0 | 3.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.9 | 6.6 | GO:0051904 | pigment granule transport(GO:0051904) |
0.9 | 1.9 | GO:0015884 | folic acid transport(GO:0015884) |
0.9 | 10.4 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.9 | 1.9 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.9 | 0.9 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.9 | 1.9 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) positive regulation of early endosome to late endosome transport(GO:2000643) |
0.9 | 4.7 | GO:0060539 | diaphragm development(GO:0060539) |
0.9 | 4.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.9 | 3.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.9 | 0.9 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.9 | 1.9 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.9 | 5.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.9 | 1.9 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.9 | 30.9 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.9 | 0.9 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.9 | 1.9 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.9 | 5.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.9 | 5.6 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.9 | 5.6 | GO:2000108 | positive regulation of leukocyte apoptotic process(GO:2000108) |
0.9 | 1.9 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.9 | 10.2 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.9 | 0.9 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.9 | 0.9 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.9 | 5.5 | GO:0001562 | response to protozoan(GO:0001562) |
0.9 | 3.7 | GO:0036344 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.9 | 1.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.9 | 2.7 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) positive regulation of enamel mineralization(GO:0070175) |
0.9 | 1.8 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.9 | 1.8 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.9 | 1.8 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.9 | 1.8 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.9 | 7.2 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.9 | 1.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.9 | 2.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.9 | 1.8 | GO:0010171 | body morphogenesis(GO:0010171) |
0.9 | 9.9 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.9 | 0.9 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.9 | 1.8 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.9 | 1.8 | GO:0050832 | defense response to fungus(GO:0050832) |
0.9 | 1.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.9 | 8.0 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.9 | 1.8 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.9 | 4.4 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.9 | 0.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.9 | 1.8 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.9 | 0.9 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.9 | 0.9 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.9 | 6.2 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.9 | 2.7 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.9 | 1.8 | GO:0046688 | response to copper ion(GO:0046688) |
0.9 | 7.9 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.9 | 1.8 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.9 | 47.6 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.9 | 2.6 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.9 | 0.9 | GO:0001781 | neutrophil apoptotic process(GO:0001781) |
0.9 | 0.9 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.9 | 4.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.9 | 4.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.9 | 5.2 | GO:0048753 | pigment granule organization(GO:0048753) |
0.9 | 6.1 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.9 | 2.6 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.9 | 2.6 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.9 | 4.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.9 | 4.3 | GO:0051154 | negative regulation of striated muscle cell differentiation(GO:0051154) |
0.9 | 4.3 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.9 | 19.0 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.9 | 1.7 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.9 | 3.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.9 | 6.0 | GO:0070633 | transepithelial transport(GO:0070633) |
0.9 | 3.4 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.9 | 0.9 | GO:0009624 | response to nematode(GO:0009624) |
0.9 | 0.9 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.8 | 1.7 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.8 | 0.8 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.8 | 2.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.8 | 10.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.8 | 0.8 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.8 | 3.3 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.8 | 7.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.8 | 1.7 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.8 | 3.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.8 | 7.4 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.8 | 1.6 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.8 | 1.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.8 | 4.1 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.8 | 31.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.8 | 4.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.8 | 4.9 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.8 | 2.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.8 | 3.3 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.8 | 2.4 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.8 | 21.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.8 | 1.6 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.8 | 0.8 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.8 | 5.6 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.8 | 3.2 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.8 | 4.8 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.8 | 2.4 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.8 | 1.6 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.8 | 0.8 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.8 | 9.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.8 | 2.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.8 | 1.6 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.8 | 7.1 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.8 | 5.5 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.8 | 3.9 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.8 | 3.1 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.8 | 10.2 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.8 | 6.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.8 | 7.0 | GO:0045576 | mast cell activation(GO:0045576) |
0.8 | 2.3 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.8 | 0.8 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.8 | 0.8 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.8 | 1.5 | GO:0070741 | response to interleukin-6(GO:0070741) cellular response to interleukin-6(GO:0071354) |
0.8 | 2.3 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.8 | 0.8 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.8 | 3.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.8 | 0.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.8 | 3.8 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.8 | 0.8 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.8 | 0.8 | GO:0033572 | transferrin transport(GO:0033572) |
0.8 | 6.8 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.8 | 4.5 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.8 | 3.0 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.7 | 2.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.7 | 0.7 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.7 | 3.0 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.7 | 6.7 | GO:0032392 | DNA geometric change(GO:0032392) |
0.7 | 1.5 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.7 | 1.5 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.7 | 4.4 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.7 | 7.4 | GO:0030168 | platelet activation(GO:0030168) |
0.7 | 8.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.7 | 5.2 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
0.7 | 1.5 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.7 | 0.7 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.7 | 2.9 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.7 | 0.7 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.7 | 15.3 | GO:0051028 | mRNA transport(GO:0051028) |
0.7 | 0.7 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.7 | 0.7 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.7 | 0.7 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.7 | 22.5 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.7 | 8.0 | GO:0019915 | lipid storage(GO:0019915) |
0.7 | 1.5 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.7 | 1.4 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.7 | 0.7 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.7 | 3.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.7 | 0.7 | GO:0015791 | polyol transport(GO:0015791) |
0.7 | 1.4 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.7 | 2.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.7 | 13.6 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.7 | 20.8 | GO:0051168 | nuclear export(GO:0051168) |
0.7 | 5.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.7 | 0.7 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.7 | 1.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.7 | 2.1 | GO:0060770 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.7 | 1.4 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.7 | 2.8 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.7 | 0.7 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.7 | 14.0 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.7 | 0.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.7 | 1.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.7 | 5.5 | GO:0048535 | lymph node development(GO:0048535) |
0.7 | 0.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.7 | 1.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.7 | 2.1 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.7 | 4.8 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.7 | 1.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.7 | 0.7 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.7 | 2.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.7 | 7.5 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.7 | 3.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.7 | 2.7 | GO:0010165 | response to X-ray(GO:0010165) |
0.7 | 1.4 | GO:0045297 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.7 | 0.7 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.7 | 20.4 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.7 | 1.4 | GO:0002159 | desmosome assembly(GO:0002159) |
0.7 | 0.7 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.7 | 0.7 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.7 | 0.7 | GO:0018377 | protein myristoylation(GO:0018377) |
0.7 | 3.4 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.7 | 2.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.7 | 8.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.7 | 0.7 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.7 | 0.7 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.7 | 0.7 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.7 | 4.6 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.7 | 3.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.6 | 1.9 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.6 | 0.6 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.6 | 12.3 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.6 | 1.9 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.6 | 0.6 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.6 | 1.9 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.6 | 0.6 | GO:1904871 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.6 | 12.8 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.6 | 0.6 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.6 | 0.6 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
0.6 | 0.6 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.6 | 3.2 | GO:0007135 | meiosis II(GO:0007135) |
0.6 | 13.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.6 | 1.3 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.6 | 0.6 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.6 | 3.1 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.6 | 3.8 | GO:0030261 | chromosome condensation(GO:0030261) |
0.6 | 0.6 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.6 | 9.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.6 | 1.9 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.6 | 3.8 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.6 | 4.4 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.6 | 2.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.6 | 1.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.6 | 5.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.6 | 2.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.6 | 1.9 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.6 | 2.5 | GO:0030432 | peristalsis(GO:0030432) |
0.6 | 1.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.6 | 2.5 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.6 | 3.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.6 | 1.8 | GO:0097264 | self proteolysis(GO:0097264) |
0.6 | 0.6 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.6 | 8.5 | GO:0006953 | acute-phase response(GO:0006953) |
0.6 | 6.7 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.6 | 0.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.6 | 4.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.6 | 1.2 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.6 | 0.6 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.6 | 0.6 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.6 | 0.6 | GO:1903203 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
0.6 | 0.6 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.6 | 20.4 | GO:0006310 | DNA recombination(GO:0006310) |
0.6 | 2.3 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.6 | 4.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.6 | 1.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.6 | 0.6 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
0.6 | 1.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.6 | 0.6 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.6 | 0.6 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.6 | 1.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.6 | 0.6 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.6 | 0.6 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.6 | 0.6 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.6 | 6.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.6 | 1.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.6 | 3.9 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.6 | 0.6 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.6 | 5.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.6 | 6.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.6 | 0.6 | GO:2000665 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.6 | 1.7 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.6 | 11.1 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.6 | 1.7 | GO:0015846 | polyamine transport(GO:0015846) |
0.5 | 0.5 | GO:0045176 | apical protein localization(GO:0045176) |
0.5 | 0.5 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.5 | 1.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.5 | 1.1 | GO:0015669 | gas transport(GO:0015669) |
0.5 | 0.5 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.5 | 4.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.5 | 4.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.5 | 3.7 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.5 | 2.6 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.5 | 14.8 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.5 | 1.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.5 | 46.5 | GO:0051607 | defense response to virus(GO:0051607) |
0.5 | 2.1 | GO:0043368 | positive T cell selection(GO:0043368) |
0.5 | 0.5 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.5 | 2.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 1.6 | GO:0015074 | DNA integration(GO:0015074) |
0.5 | 1.6 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.5 | 0.5 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.5 | 3.6 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.5 | 1.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.5 | 4.1 | GO:0007127 | meiosis I(GO:0007127) |
0.5 | 3.6 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.5 | 4.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.5 | 2.5 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.5 | 1.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.5 | 1.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.5 | 2.5 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.5 | 0.5 | GO:0043038 | amino acid activation(GO:0043038) |
0.5 | 6.5 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.5 | 4.0 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.5 | 0.5 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.5 | 2.5 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.5 | 1.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.5 | 1.5 | GO:0015825 | L-serine transport(GO:0015825) |
0.5 | 3.0 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.5 | 1.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.5 | 1.0 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.5 | 4.9 | GO:0042991 | transcription factor import into nucleus(GO:0042991) |
0.5 | 2.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.5 | 6.4 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.5 | 2.9 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
0.5 | 1.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.5 | 1.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.5 | 1.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.5 | 1.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.5 | 4.8 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.5 | 2.4 | GO:0015858 | nucleoside transport(GO:0015858) |
0.5 | 11.0 | GO:0030816 | positive regulation of cAMP metabolic process(GO:0030816) |
0.5 | 0.5 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.5 | 1.4 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.5 | 0.9 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.5 | 23.1 | GO:0008033 | tRNA processing(GO:0008033) |
0.5 | 0.9 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.5 | 6.6 | GO:0000723 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.5 | 0.5 | GO:0015747 | urate transport(GO:0015747) |
0.5 | 0.5 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.5 | 0.9 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.5 | 0.5 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.5 | 7.0 | GO:0007492 | endoderm development(GO:0007492) |
0.5 | 0.5 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.5 | 0.5 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.5 | 0.9 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.5 | 1.8 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.5 | 0.5 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.5 | 9.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.5 | 0.9 | GO:0051584 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.4 | 4.5 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.4 | 2.7 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.4 | 4.0 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.4 | 1.3 | GO:0033198 | response to ATP(GO:0033198) |
0.4 | 0.9 | GO:0046416 | D-amino acid catabolic process(GO:0019478) D-amino acid metabolic process(GO:0046416) |
0.4 | 1.3 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.4 | 6.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.4 | 0.4 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.4 | 0.9 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.4 | 3.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.4 | 2.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.4 | 0.9 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.4 | 0.4 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.4 | 2.6 | GO:0033273 | response to vitamin(GO:0033273) |
0.4 | 5.5 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.4 | 2.5 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.4 | 13.4 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.4 | 2.9 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.4 | 4.6 | GO:0035904 | aorta development(GO:0035904) |
0.4 | 9.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.4 | 2.1 | GO:0042159 | protein depalmitoylation(GO:0002084) lipoprotein catabolic process(GO:0042159) macromolecule depalmitoylation(GO:0098734) |
0.4 | 1.2 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.4 | 1.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.4 | 3.6 | GO:0046683 | response to organophosphorus(GO:0046683) |
0.4 | 3.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.4 | 4.4 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 1.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.4 | 0.4 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.4 | 2.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.4 | 0.4 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.4 | 0.8 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.4 | 5.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.4 | 0.4 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.4 | 1.6 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.4 | 0.4 | GO:0072683 | T cell extravasation(GO:0072683) |
0.4 | 2.7 | GO:0034505 | tooth mineralization(GO:0034505) |
0.4 | 0.4 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.4 | 0.8 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.4 | 0.8 | GO:0051775 | response to redox state(GO:0051775) |
0.4 | 2.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.4 | 37.1 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.4 | 1.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.4 | 0.4 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) |
0.4 | 0.4 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.4 | 1.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.4 | 0.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.4 | 4.8 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.4 | 1.9 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.4 | 0.4 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.4 | 1.1 | GO:0032637 | interleukin-8 production(GO:0032637) |
0.4 | 2.6 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.4 | 3.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.4 | 3.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.4 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.4 | 1.1 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.4 | 0.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.4 | 3.6 | GO:0014850 | response to muscle activity(GO:0014850) |
0.4 | 9.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.4 | 23.0 | GO:0006457 | protein folding(GO:0006457) |
0.4 | 0.4 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.4 | 0.4 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.4 | 0.4 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.4 | 1.4 | GO:0016322 | neuron remodeling(GO:0016322) |
0.4 | 1.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 0.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.4 | 0.7 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.4 | 1.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.4 | 0.7 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.4 | 1.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.3 | 2.1 | GO:0006825 | copper ion transport(GO:0006825) |
0.3 | 1.0 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.3 | 2.8 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.3 | 2.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.3 | 0.7 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.3 | 1.0 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.3 | 0.7 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.3 | 0.3 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.3 | 0.3 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.3 | 3.3 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.3 | 0.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 0.3 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.3 | 0.3 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.3 | 0.7 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.3 | 0.3 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.3 | 0.3 | GO:0033058 | directional locomotion(GO:0033058) |
0.3 | 0.3 | GO:0071025 | RNA surveillance(GO:0071025) |
0.3 | 1.6 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.3 | 1.0 | GO:1902110 | positive regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902110) mitochondrial outer membrane permeabilization involved in programmed cell death(GO:1902686) |
0.3 | 26.1 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.3 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 0.3 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.3 | 6.1 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
0.3 | 1.3 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.3 | 1.9 | GO:0007584 | response to nutrient(GO:0007584) |
0.3 | 0.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.3 | 0.9 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.3 | 1.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.3 | 0.6 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.3 | 2.5 | GO:0009411 | response to UV(GO:0009411) |
0.3 | 1.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 0.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.3 | 1.9 | GO:0050892 | intestinal absorption(GO:0050892) |
0.3 | 3.7 | GO:0042596 | fear response(GO:0042596) |
0.3 | 0.6 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.3 | 31.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.3 | 13.3 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.3 | 0.6 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.3 | 0.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.3 | 1.2 | GO:0045453 | bone resorption(GO:0045453) |
0.3 | 0.6 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 0.6 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.3 | 0.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.3 | 0.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 0.3 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
0.3 | 1.5 | GO:1901988 | negative regulation of cell cycle phase transition(GO:1901988) |
0.3 | 0.6 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 2.0 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.3 | 1.7 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.3 | 3.2 | GO:0019835 | cytolysis(GO:0019835) |
0.3 | 0.3 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.3 | 0.3 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.3 | 7.0 | GO:0015758 | glucose transport(GO:0015758) |
0.3 | 0.6 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.3 | 1.6 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.3 | 1.4 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.3 | 1.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 2.2 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.3 | 0.3 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
0.3 | 0.3 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.3 | 2.4 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.3 | 1.0 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 0.5 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.3 | 0.3 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.3 | 0.8 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.3 | 0.5 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.3 | 0.8 | GO:0030539 | male genitalia development(GO:0030539) |
0.3 | 0.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.3 | 6.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.3 | 1.0 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.2 | 0.5 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.2 | 0.2 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 1.7 | GO:0010518 | positive regulation of phospholipase activity(GO:0010518) |
0.2 | 1.0 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.2 | 1.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.2 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 0.2 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 1.4 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 18.4 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.2 | 0.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.2 | 2.0 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.2 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 3.8 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.2 | 1.5 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.2 | 0.2 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.2 | 0.2 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.2 | 0.4 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.2 | 2.6 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
0.2 | 0.2 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.2 | 0.6 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.2 | 0.6 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 0.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 1.0 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.2 | 0.2 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.2 | 0.6 | GO:0032418 | lysosome localization(GO:0032418) |
0.2 | 0.6 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 1.0 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.2 | 0.2 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) intestine smooth muscle contraction(GO:0014827) |
0.2 | 0.8 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 0.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 0.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.2 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 1.5 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.2 | 0.6 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) |
0.2 | 2.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 16.2 | GO:0032259 | methylation(GO:0032259) |
0.2 | 0.2 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.2 | 0.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 2.3 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.2 | 0.5 | GO:0018205 | peptidyl-lysine modification(GO:0018205) |
0.2 | 0.2 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.2 | 4.3 | GO:1903747 | regulation of establishment of protein localization to mitochondrion(GO:1903747) |
0.2 | 0.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 1.9 | GO:0051384 | response to glucocorticoid(GO:0051384) |
0.2 | 186.1 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.2 | 0.2 | GO:0006403 | RNA localization(GO:0006403) |
0.2 | 5.2 | GO:0019318 | hexose metabolic process(GO:0019318) |
0.2 | 0.5 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.2 | 8.3 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.2 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 2.1 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 0.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 0.2 | GO:1900024 | regulation of substrate adhesion-dependent cell spreading(GO:1900024) |
0.2 | 0.5 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.1 | 0.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.3 | GO:1903429 | regulation of cell maturation(GO:1903429) |
0.1 | 0.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.1 | 5.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.6 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.1 | 0.1 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.1 | 7.9 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.1 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
0.1 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 1.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.9 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.3 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.1 | 0.4 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.1 | 1.6 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.1 | 0.4 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.1 | GO:1902591 | single-organism membrane budding(GO:1902591) |
0.1 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.2 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.1 | 1.4 | GO:2000107 | negative regulation of leukocyte apoptotic process(GO:2000107) |
0.1 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.1 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.3 | GO:0006304 | DNA modification(GO:0006304) |
0.1 | 0.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.1 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.2 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.1 | 1.0 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 2.5 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.6 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 5.4 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.1 | 0.6 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 4.4 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.1 | 2.4 | GO:0051297 | centrosome organization(GO:0051297) |
0.1 | 0.6 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 6.6 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.5 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.2 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) coenzyme transport(GO:0051182) |
0.1 | 0.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.1 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.1 | 0.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.1 | GO:0006497 | protein lipidation(GO:0006497) |
0.1 | 0.9 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.1 | 0.5 | GO:0097369 | sodium ion import(GO:0097369) |
0.1 | 0.2 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.1 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.1 | 0.1 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.7 | GO:0006959 | humoral immune response(GO:0006959) |
0.1 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 1.3 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.1 | 0.2 | GO:0060746 | parental behavior(GO:0060746) |
0.1 | 0.7 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.1 | 0.1 | GO:0018394 | peptidyl-lysine acetylation(GO:0018394) |
0.1 | 0.1 | GO:0009620 | response to fungus(GO:0009620) |
0.1 | 0.1 | GO:0043543 | protein acylation(GO:0043543) |
0.1 | 0.1 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.1 | 0.1 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.2 | GO:0044272 | sulfur compound biosynthetic process(GO:0044272) |
0.0 | 5.2 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.0 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.0 | GO:0015810 | aspartate transport(GO:0015810) |
0.0 | 0.0 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 1.0 | GO:0007599 | hemostasis(GO:0007599) |
0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.0 | GO:0071696 | ectodermal placode development(GO:0071696) |
0.0 | 0.5 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.0 | 0.0 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 0.0 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.0 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.0 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
0.0 | 0.0 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.0 | 0.0 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.0 | GO:0006971 | hypotonic response(GO:0006971) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
33.7 | 168.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
11.2 | 33.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
10.7 | 64.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
9.6 | 28.9 | GO:0005745 | m-AAA complex(GO:0005745) |
9.3 | 37.4 | GO:1990130 | Iml1 complex(GO:1990130) |
8.1 | 24.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
8.0 | 23.9 | GO:0044393 | microspike(GO:0044393) |
7.6 | 38.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
7.6 | 60.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
7.2 | 35.8 | GO:0008091 | spectrin(GO:0008091) |
7.0 | 55.8 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
6.8 | 40.9 | GO:1990462 | omegasome(GO:1990462) |
6.6 | 26.2 | GO:0097450 | astrocyte end-foot(GO:0097450) |
6.5 | 19.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
6.4 | 12.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
6.4 | 19.1 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
6.3 | 94.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
6.3 | 18.8 | GO:0032127 | dense core granule membrane(GO:0032127) |
6.1 | 36.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
6.1 | 42.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
6.1 | 18.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
5.9 | 23.7 | GO:0042583 | chromaffin granule(GO:0042583) |
5.9 | 17.7 | GO:0016939 | kinesin II complex(GO:0016939) |
5.9 | 17.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
5.8 | 17.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
5.8 | 52.0 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
5.8 | 17.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
5.5 | 27.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
5.5 | 22.0 | GO:0031094 | platelet dense tubular network(GO:0031094) |
5.4 | 59.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
5.2 | 31.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
5.0 | 10.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
5.0 | 19.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
4.9 | 24.4 | GO:0097422 | tubular endosome(GO:0097422) |
4.8 | 4.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
4.8 | 28.7 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
4.7 | 18.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
4.7 | 37.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
4.5 | 18.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
4.4 | 13.3 | GO:0005912 | adherens junction(GO:0005912) |
4.2 | 29.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
4.2 | 16.7 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
4.2 | 20.9 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
4.1 | 28.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
4.1 | 12.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
4.1 | 20.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
4.0 | 16.0 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
4.0 | 15.9 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
4.0 | 23.8 | GO:0016589 | NURF complex(GO:0016589) |
3.9 | 94.3 | GO:0097228 | sperm principal piece(GO:0097228) |
3.9 | 11.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
3.8 | 11.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
3.8 | 11.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
3.8 | 30.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
3.7 | 18.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
3.7 | 18.4 | GO:0005638 | lamin filament(GO:0005638) |
3.6 | 21.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
3.6 | 32.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
3.6 | 28.5 | GO:0034464 | BBSome(GO:0034464) |
3.5 | 17.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
3.5 | 3.5 | GO:1990423 | RZZ complex(GO:1990423) |
3.5 | 55.9 | GO:0002102 | podosome(GO:0002102) |
3.4 | 3.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
3.4 | 13.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
3.4 | 27.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
3.4 | 239.0 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
3.4 | 13.4 | GO:0034704 | calcium channel complex(GO:0034704) |
3.3 | 30.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
3.2 | 3.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
3.2 | 3.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
3.2 | 12.9 | GO:0035339 | SPOTS complex(GO:0035339) |
3.2 | 12.8 | GO:1990745 | EARP complex(GO:1990745) |
3.2 | 15.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
3.2 | 12.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
3.1 | 31.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
3.1 | 27.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
3.1 | 9.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
3.1 | 42.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
3.0 | 30.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
3.0 | 9.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
3.0 | 8.9 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
3.0 | 17.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
3.0 | 5.9 | GO:0045298 | tubulin complex(GO:0045298) |
2.9 | 129.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
2.9 | 20.5 | GO:0042382 | paraspeckles(GO:0042382) |
2.9 | 8.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
2.9 | 8.6 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
2.9 | 11.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
2.9 | 2.9 | GO:0005652 | nuclear lamina(GO:0005652) |
2.8 | 8.5 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
2.8 | 2.8 | GO:0000938 | GARP complex(GO:0000938) |
2.8 | 11.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
2.8 | 2.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
2.8 | 2.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
2.8 | 5.6 | GO:0032010 | phagolysosome(GO:0032010) |
2.8 | 11.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
2.8 | 11.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
2.7 | 19.2 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
2.7 | 11.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
2.7 | 38.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
2.7 | 19.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
2.7 | 10.9 | GO:0031256 | leading edge membrane(GO:0031256) |
2.7 | 16.3 | GO:0031415 | NatA complex(GO:0031415) |
2.7 | 51.3 | GO:0045120 | pronucleus(GO:0045120) |
2.7 | 16.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
2.7 | 8.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
2.7 | 21.5 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
2.7 | 58.7 | GO:0090544 | BAF-type complex(GO:0090544) |
2.6 | 36.9 | GO:0097440 | apical dendrite(GO:0097440) |
2.6 | 44.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
2.6 | 10.5 | GO:0098536 | deuterosome(GO:0098536) |
2.6 | 15.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
2.6 | 7.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
2.6 | 10.4 | GO:0071797 | LUBAC complex(GO:0071797) |
2.6 | 7.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
2.6 | 26.1 | GO:0008278 | cohesin complex(GO:0008278) |
2.6 | 10.4 | GO:0033269 | internode region of axon(GO:0033269) |
2.5 | 12.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
2.5 | 15.2 | GO:0005818 | aster(GO:0005818) |
2.5 | 25.3 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
2.5 | 24.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
2.5 | 9.9 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
2.5 | 14.8 | GO:0071986 | Ragulator complex(GO:0071986) |
2.5 | 7.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
2.5 | 56.4 | GO:0008305 | integrin complex(GO:0008305) |
2.4 | 2.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
2.4 | 2.4 | GO:0005767 | secondary lysosome(GO:0005767) |
2.4 | 25.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
2.3 | 4.6 | GO:0016459 | myosin complex(GO:0016459) |
2.3 | 16.2 | GO:0031931 | TORC1 complex(GO:0031931) |
2.3 | 20.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
2.3 | 13.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
2.2 | 8.9 | GO:0042825 | TAP complex(GO:0042825) |
2.2 | 4.4 | GO:0089701 | U2AF(GO:0089701) |
2.2 | 8.9 | GO:0098794 | postsynapse(GO:0098794) |
2.2 | 22.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
2.2 | 6.5 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
2.2 | 6.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
2.2 | 93.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
2.2 | 8.7 | GO:0097452 | GAIT complex(GO:0097452) |
2.2 | 26.0 | GO:0031528 | microvillus membrane(GO:0031528) |
2.1 | 15.0 | GO:0071437 | invadopodium(GO:0071437) |
2.1 | 48.3 | GO:0031941 | filamentous actin(GO:0031941) |
2.1 | 18.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
2.1 | 18.8 | GO:0010369 | chromocenter(GO:0010369) |
2.1 | 12.6 | GO:0016600 | flotillin complex(GO:0016600) |
2.1 | 8.4 | GO:0045293 | mRNA editing complex(GO:0045293) |
2.1 | 27.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
2.1 | 53.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
2.1 | 4.1 | GO:0098576 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) lumenal side of membrane(GO:0098576) |
2.0 | 14.3 | GO:0071546 | pi-body(GO:0071546) |
2.0 | 10.2 | GO:0005883 | neurofilament(GO:0005883) |
2.0 | 4.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
2.0 | 30.6 | GO:0005795 | Golgi stack(GO:0005795) |
2.0 | 14.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
2.0 | 4.0 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
2.0 | 18.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
2.0 | 10.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
2.0 | 4.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
2.0 | 114.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
2.0 | 21.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
2.0 | 6.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
2.0 | 8.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
2.0 | 5.9 | GO:0005955 | calcineurin complex(GO:0005955) |
2.0 | 76.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
2.0 | 9.8 | GO:0051286 | cell tip(GO:0051286) |
2.0 | 5.9 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
2.0 | 2.0 | GO:0034709 | methylosome(GO:0034709) |
1.9 | 7.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.9 | 15.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.9 | 31.0 | GO:0000145 | exocyst(GO:0000145) |
1.9 | 5.8 | GO:0032426 | stereocilium tip(GO:0032426) |
1.9 | 30.9 | GO:0001673 | male germ cell nucleus(GO:0001673) |
1.9 | 3.9 | GO:1990923 | PET complex(GO:1990923) |
1.9 | 21.2 | GO:0044292 | dendrite terminus(GO:0044292) |
1.9 | 5.8 | GO:0097413 | Lewy body(GO:0097413) |
1.9 | 7.7 | GO:0043073 | germ cell nucleus(GO:0043073) |
1.9 | 65.1 | GO:0016592 | mediator complex(GO:0016592) |
1.9 | 15.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.9 | 30.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
1.9 | 20.8 | GO:0001527 | microfibril(GO:0001527) |
1.9 | 18.7 | GO:0001891 | phagocytic cup(GO:0001891) |
1.8 | 5.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
1.8 | 99.4 | GO:0016363 | nuclear matrix(GO:0016363) |
1.8 | 3.7 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
1.8 | 5.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.8 | 28.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
1.8 | 7.2 | GO:0070545 | PeBoW complex(GO:0070545) |
1.8 | 16.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
1.8 | 35.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.8 | 1.8 | GO:0001652 | granular component(GO:0001652) |
1.7 | 45.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.7 | 5.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.7 | 10.4 | GO:0032009 | early phagosome(GO:0032009) |
1.7 | 6.9 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
1.7 | 10.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
1.7 | 25.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.7 | 13.6 | GO:0030673 | axolemma(GO:0030673) |
1.7 | 1.7 | GO:0043219 | lateral loop(GO:0043219) |
1.7 | 1.7 | GO:0061574 | ASAP complex(GO:0061574) |
1.7 | 3.4 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.7 | 3.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.7 | 6.6 | GO:0031983 | vesicle lumen(GO:0031983) |
1.7 | 18.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.7 | 5.0 | GO:0045179 | apical cortex(GO:0045179) |
1.7 | 16.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
1.6 | 8.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
1.6 | 4.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.6 | 38.8 | GO:0005876 | spindle microtubule(GO:0005876) |
1.6 | 3.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.6 | 30.4 | GO:0031901 | early endosome membrane(GO:0031901) |
1.6 | 4.8 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
1.6 | 23.9 | GO:0010008 | endosome membrane(GO:0010008) |
1.6 | 14.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.6 | 6.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
1.6 | 19.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
1.6 | 17.4 | GO:0000786 | nucleosome(GO:0000786) |
1.6 | 4.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.6 | 34.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.6 | 1.6 | GO:0071203 | WASH complex(GO:0071203) |
1.6 | 4.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.6 | 7.8 | GO:0001650 | fibrillar center(GO:0001650) |
1.6 | 4.7 | GO:0005914 | spot adherens junction(GO:0005914) |
1.6 | 1.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.6 | 17.2 | GO:0032039 | integrator complex(GO:0032039) |
1.6 | 4.7 | GO:0097443 | sorting endosome(GO:0097443) |
1.6 | 17.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
1.6 | 4.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.5 | 18.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
1.5 | 7.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.5 | 15.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
1.5 | 7.6 | GO:0005796 | Golgi lumen(GO:0005796) |
1.5 | 9.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.5 | 18.3 | GO:0033202 | DNA helicase complex(GO:0033202) |
1.5 | 18.2 | GO:0043196 | varicosity(GO:0043196) |
1.5 | 7.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
1.5 | 125.6 | GO:0000793 | condensed chromosome(GO:0000793) |
1.5 | 39.3 | GO:0005776 | autophagosome(GO:0005776) |
1.5 | 10.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.5 | 7.5 | GO:0072687 | meiotic spindle(GO:0072687) |
1.5 | 1.5 | GO:0031523 | Myb complex(GO:0031523) |
1.5 | 43.5 | GO:0005643 | nuclear pore(GO:0005643) |
1.5 | 1.5 | GO:0045178 | basal part of cell(GO:0045178) |
1.5 | 11.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.5 | 3.0 | GO:0033270 | paranode region of axon(GO:0033270) |
1.5 | 7.4 | GO:0005683 | U7 snRNP(GO:0005683) |
1.5 | 10.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.5 | 8.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.5 | 33.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.4 | 5.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
1.4 | 10.1 | GO:0033391 | chromatoid body(GO:0033391) |
1.4 | 74.7 | GO:0016605 | PML body(GO:0016605) |
1.4 | 20.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
1.4 | 68.8 | GO:0031526 | brush border membrane(GO:0031526) |
1.4 | 11.5 | GO:0042581 | specific granule(GO:0042581) |
1.4 | 22.9 | GO:0043197 | dendritic spine(GO:0043197) |
1.4 | 15.7 | GO:0000242 | pericentriolar material(GO:0000242) |
1.4 | 4.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
1.4 | 12.8 | GO:0051233 | spindle midzone(GO:0051233) |
1.4 | 9.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
1.4 | 1.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.4 | 14.0 | GO:0070852 | cell body fiber(GO:0070852) |
1.4 | 19.6 | GO:0035861 | site of double-strand break(GO:0035861) |
1.4 | 22.3 | GO:0030894 | replisome(GO:0030894) |
1.4 | 8.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.4 | 9.7 | GO:0070652 | HAUS complex(GO:0070652) |
1.4 | 12.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.4 | 1.4 | GO:0030880 | RNA polymerase complex(GO:0030880) |
1.4 | 4.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
1.4 | 42.5 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
1.4 | 58.8 | GO:0005811 | lipid particle(GO:0005811) |
1.4 | 15.0 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
1.4 | 39.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
1.4 | 2.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.4 | 27.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
1.3 | 13.4 | GO:0005685 | U1 snRNP(GO:0005685) |
1.3 | 142.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
1.3 | 10.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.3 | 19.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.3 | 75.8 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
1.3 | 22.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
1.3 | 1.3 | GO:0090543 | Flemming body(GO:0090543) |
1.3 | 13.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.3 | 5.2 | GO:0030056 | hemidesmosome(GO:0030056) |
1.3 | 5.2 | GO:0071817 | MMXD complex(GO:0071817) |
1.3 | 2.6 | GO:0043083 | synaptic cleft(GO:0043083) |
1.3 | 3.9 | GO:0071439 | clathrin complex(GO:0071439) |
1.3 | 20.5 | GO:0015030 | Cajal body(GO:0015030) |
1.3 | 3.8 | GO:0000125 | PCAF complex(GO:0000125) |
1.3 | 3.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.3 | 8.9 | GO:0032797 | SMN complex(GO:0032797) |
1.3 | 5.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.3 | 16.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
1.3 | 2.5 | GO:0045177 | apical part of cell(GO:0045177) |
1.3 | 3.8 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
1.3 | 64.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
1.3 | 5.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
1.3 | 2.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
1.3 | 2.5 | GO:0000805 | X chromosome(GO:0000805) |
1.3 | 2.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.2 | 5.0 | GO:0030689 | Noc complex(GO:0030689) |
1.2 | 79.7 | GO:1990204 | oxidoreductase complex(GO:1990204) |
1.2 | 21.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
1.2 | 5.0 | GO:0005642 | annulate lamellae(GO:0005642) |
1.2 | 81.1 | GO:0055037 | recycling endosome(GO:0055037) |
1.2 | 39.2 | GO:0031519 | PcG protein complex(GO:0031519) |
1.2 | 6.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
1.2 | 2.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
1.2 | 2.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.2 | 17.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
1.2 | 77.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
1.2 | 1.2 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
1.2 | 10.6 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
1.2 | 20.0 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
1.2 | 74.0 | GO:0000502 | proteasome complex(GO:0000502) |
1.2 | 9.3 | GO:0042587 | glycogen granule(GO:0042587) |
1.2 | 6.9 | GO:0031512 | motile primary cilium(GO:0031512) |
1.2 | 9.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
1.1 | 9.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.1 | 38.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
1.1 | 3.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.1 | 3.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.1 | 12.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
1.1 | 3.4 | GO:0044194 | cytolytic granule(GO:0044194) |
1.1 | 6.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.1 | 47.9 | GO:0005938 | cell cortex(GO:0005938) |
1.1 | 37.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.1 | 3.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.1 | 2.2 | GO:0031143 | pseudopodium(GO:0031143) |
1.1 | 9.9 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
1.1 | 2.2 | GO:0036157 | outer dynein arm(GO:0036157) |
1.1 | 4.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.1 | 71.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
1.1 | 50.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
1.1 | 6.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
1.0 | 1037.0 | GO:0005829 | cytosol(GO:0005829) |
1.0 | 1.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.0 | 47.7 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
1.0 | 3.1 | GO:0031417 | NatC complex(GO:0031417) |
1.0 | 54.5 | GO:0005819 | spindle(GO:0005819) |
1.0 | 2.1 | GO:0097255 | R2TP complex(GO:0097255) |
1.0 | 13.3 | GO:0001772 | immunological synapse(GO:0001772) |
1.0 | 1.0 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.0 | 17.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
1.0 | 57.7 | GO:0031965 | nuclear membrane(GO:0031965) |
1.0 | 8.1 | GO:0032421 | stereocilium bundle(GO:0032421) |
1.0 | 7.1 | GO:0000346 | transcription export complex(GO:0000346) |
1.0 | 11.1 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
1.0 | 3.0 | GO:0098552 | side of membrane(GO:0098552) |
1.0 | 8.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
1.0 | 3.9 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.0 | 18.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
1.0 | 75.3 | GO:0072562 | blood microparticle(GO:0072562) |
1.0 | 7.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
1.0 | 1.9 | GO:0005902 | microvillus(GO:0005902) |
1.0 | 5.8 | GO:0005844 | polysome(GO:0005844) |
1.0 | 2.9 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
1.0 | 11.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.9 | 0.9 | GO:0097433 | dense body(GO:0097433) |
0.9 | 63.4 | GO:0005770 | late endosome(GO:0005770) |
0.9 | 152.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.9 | 4.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.9 | 4.6 | GO:0031430 | M band(GO:0031430) |
0.9 | 2.7 | GO:0043205 | fibril(GO:0043205) |
0.9 | 2.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.9 | 13.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.9 | 8.8 | GO:0030057 | desmosome(GO:0030057) |
0.9 | 4.4 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.9 | 17.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.8 | 152.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.8 | 1.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.8 | 0.8 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.8 | 2.5 | GO:0072487 | MSL complex(GO:0072487) |
0.8 | 1.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.8 | 0.8 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.8 | 0.8 | GO:0030315 | T-tubule(GO:0030315) |
0.8 | 14.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.8 | 6.5 | GO:0005911 | cell-cell junction(GO:0005911) |
0.8 | 4.9 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.8 | 0.8 | GO:0044440 | endosomal part(GO:0044440) |
0.8 | 8.9 | GO:0016234 | inclusion body(GO:0016234) |
0.8 | 33.9 | GO:0005635 | nuclear envelope(GO:0005635) |
0.8 | 781.0 | GO:0005654 | nucleoplasm(GO:0005654) |
0.8 | 7.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.8 | 95.4 | GO:0005925 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) |
0.8 | 14.9 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.8 | 0.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.8 | 61.5 | GO:0030133 | transport vesicle(GO:0030133) |
0.8 | 6.1 | GO:0030054 | cell junction(GO:0030054) |
0.8 | 5.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.7 | 1.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.7 | 2.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.7 | 8.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.7 | 0.7 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.7 | 557.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.7 | 2.9 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.7 | 0.7 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.7 | 16.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.7 | 2.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.7 | 478.2 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.7 | 2.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.7 | 0.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.7 | 2.7 | GO:0014704 | intercalated disc(GO:0014704) |
0.7 | 2.0 | GO:0002177 | manchette(GO:0002177) |
0.7 | 12.5 | GO:0012505 | endomembrane system(GO:0012505) |
0.7 | 2.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.7 | 66.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.6 | 2.6 | GO:0030424 | axon(GO:0030424) |
0.6 | 8.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.6 | 1.9 | GO:0032982 | myosin filament(GO:0032982) |
0.6 | 7.5 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.6 | 3.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.6 | 67.3 | GO:0005874 | microtubule(GO:0005874) |
0.6 | 1.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.6 | 46.7 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.6 | 18.3 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.6 | 10.8 | GO:0036126 | sperm flagellum(GO:0036126) |
0.6 | 8.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.6 | 1.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.5 | 7.0 | GO:0031514 | motile cilium(GO:0031514) |
0.5 | 28.4 | GO:0097223 | sperm part(GO:0097223) |
0.5 | 1.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.5 | 0.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.5 | 55.9 | GO:0005694 | chromosome(GO:0005694) |
0.5 | 1.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.5 | 8.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.5 | 1.0 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.5 | 7.1 | GO:0042641 | actomyosin(GO:0042641) |
0.5 | 16.1 | GO:0005769 | early endosome(GO:0005769) |
0.5 | 1.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.5 | 20.2 | GO:0000139 | Golgi membrane(GO:0000139) |
0.5 | 1.9 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.5 | 10.2 | GO:0005921 | gap junction(GO:0005921) |
0.5 | 3.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.4 | 2.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 1.3 | GO:0042599 | lamellar body(GO:0042599) |
0.4 | 0.9 | GO:0043203 | axon hillock(GO:0043203) |
0.4 | 0.9 | GO:1904949 | ATPase complex(GO:1904949) |
0.4 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 0.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.4 | 1.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.4 | 0.8 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 25.2 | GO:0005768 | endosome(GO:0005768) |
0.4 | 10.3 | GO:0005814 | centriole(GO:0005814) |
0.4 | 1311.7 | GO:0016021 | integral component of membrane(GO:0016021) |
0.4 | 0.4 | GO:0043209 | myelin sheath(GO:0043209) |
0.4 | 0.7 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.4 | 27.5 | GO:0005813 | centrosome(GO:0005813) |
0.4 | 11.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.4 | 11.2 | GO:0009986 | cell surface(GO:0009986) |
0.3 | 0.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 0.7 | GO:0005840 | ribosome(GO:0005840) |
0.3 | 0.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 1.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 32.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 18.8 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.3 | 0.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.3 | 0.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 13.9 | GO:0043292 | contractile fiber(GO:0043292) |
0.2 | 2.7 | GO:0005773 | vacuole(GO:0005773) |
0.2 | 89.3 | GO:0005615 | extracellular space(GO:0005615) |
0.2 | 0.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 0.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 0.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.2 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 495.9 | GO:0043227 | membrane-bounded organelle(GO:0043227) |
0.2 | 1.4 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 0.9 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 2.0 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 39.4 | GO:0016020 | membrane(GO:0016020) |
0.1 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 8.9 | GO:0005576 | extracellular region(GO:0005576) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
42.7 | 170.8 | GO:0031720 | haptoglobin binding(GO:0031720) |
16.7 | 66.7 | GO:0015265 | urea channel activity(GO:0015265) |
15.2 | 106.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
15.1 | 45.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
14.7 | 44.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
12.7 | 50.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
11.7 | 35.2 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
11.5 | 23.0 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
11.4 | 45.5 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
10.7 | 42.7 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
10.4 | 52.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
10.1 | 40.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
10.1 | 80.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
9.6 | 28.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
9.6 | 38.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
8.5 | 42.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
8.5 | 51.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
8.4 | 33.7 | GO:0038100 | nodal binding(GO:0038100) |
8.3 | 25.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
8.0 | 64.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
7.7 | 54.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
7.7 | 7.7 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
7.6 | 30.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
7.6 | 30.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
7.4 | 7.4 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
7.1 | 21.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
7.0 | 28.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
7.0 | 21.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
6.9 | 20.8 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
6.8 | 137.0 | GO:0030506 | ankyrin binding(GO:0030506) |
6.6 | 13.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
6.5 | 19.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
6.5 | 32.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
6.4 | 38.6 | GO:0004064 | arylesterase activity(GO:0004064) |
6.4 | 38.4 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
6.4 | 19.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
6.3 | 31.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
6.2 | 24.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
6.0 | 18.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
6.0 | 11.9 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
5.9 | 23.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
5.8 | 23.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
5.8 | 40.5 | GO:0016803 | ether hydrolase activity(GO:0016803) |
5.6 | 16.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
5.5 | 44.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
5.5 | 49.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
5.5 | 21.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
5.5 | 38.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
5.5 | 16.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
5.5 | 5.5 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
5.4 | 27.2 | GO:0070061 | fructose binding(GO:0070061) |
5.4 | 10.9 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
5.3 | 16.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
5.3 | 26.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
5.3 | 10.6 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
5.3 | 15.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
5.2 | 31.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
5.2 | 5.2 | GO:0051723 | protein methylesterase activity(GO:0051723) |
5.1 | 15.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
5.1 | 5.1 | GO:0030984 | kininogen binding(GO:0030984) |
5.0 | 15.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
5.0 | 69.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
4.8 | 14.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
4.8 | 38.6 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
4.8 | 14.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
4.7 | 84.9 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
4.7 | 18.8 | GO:0015232 | heme transporter activity(GO:0015232) |
4.6 | 13.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
4.5 | 27.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
4.5 | 13.5 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
4.5 | 17.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
4.5 | 17.9 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
4.5 | 17.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
4.4 | 8.9 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) amidine-lyase activity(GO:0016842) |
4.4 | 57.2 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
4.4 | 13.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
4.4 | 21.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
4.3 | 39.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
4.3 | 8.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
4.3 | 13.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
4.3 | 29.9 | GO:0019534 | toxin transporter activity(GO:0019534) |
4.3 | 38.4 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
4.3 | 4.3 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
4.2 | 89.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
4.2 | 16.9 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
4.2 | 42.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
4.2 | 12.6 | GO:0038181 | bile acid receptor activity(GO:0038181) |
4.2 | 54.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
4.1 | 12.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
4.1 | 8.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
4.1 | 36.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
4.0 | 8.0 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
4.0 | 8.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
4.0 | 36.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
4.0 | 27.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
4.0 | 127.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
4.0 | 15.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
3.9 | 11.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
3.9 | 15.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
3.9 | 15.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
3.9 | 15.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
3.9 | 15.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
3.9 | 11.7 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
3.9 | 15.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
3.8 | 11.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
3.8 | 69.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
3.8 | 15.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
3.8 | 11.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
3.8 | 11.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
3.8 | 11.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
3.8 | 11.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
3.8 | 72.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
3.8 | 11.3 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
3.7 | 22.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
3.7 | 14.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
3.7 | 22.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
3.7 | 40.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
3.6 | 14.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
3.6 | 36.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
3.6 | 10.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
3.6 | 78.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
3.6 | 28.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
3.5 | 10.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
3.5 | 31.4 | GO:0034863 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
3.5 | 24.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
3.5 | 20.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
3.4 | 20.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
3.4 | 10.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
3.4 | 13.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
3.4 | 16.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
3.3 | 6.7 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
3.3 | 26.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
3.3 | 6.7 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
3.3 | 10.0 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
3.3 | 19.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
3.3 | 9.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
3.2 | 6.5 | GO:0015928 | fucosidase activity(GO:0015928) |
3.2 | 58.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
3.2 | 12.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
3.2 | 48.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
3.2 | 12.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
3.2 | 19.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
3.2 | 22.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
3.2 | 70.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
3.2 | 73.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
3.2 | 9.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
3.2 | 9.5 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
3.2 | 15.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
3.2 | 6.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
3.2 | 15.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
3.2 | 12.6 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
3.1 | 9.4 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
3.1 | 6.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
3.1 | 9.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
3.1 | 43.1 | GO:0005521 | lamin binding(GO:0005521) |
3.1 | 30.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
3.1 | 180.5 | GO:0016836 | hydro-lyase activity(GO:0016836) |
3.0 | 18.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
3.0 | 3.0 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
3.0 | 12.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
3.0 | 9.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
3.0 | 18.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
3.0 | 45.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
3.0 | 12.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
3.0 | 20.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
3.0 | 11.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
3.0 | 11.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
3.0 | 6.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
3.0 | 26.7 | GO:0039706 | co-receptor binding(GO:0039706) |
3.0 | 29.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
2.9 | 8.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
2.9 | 14.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
2.9 | 20.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
2.9 | 11.5 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
2.9 | 8.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
2.9 | 2.9 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
2.9 | 42.9 | GO:0001848 | complement binding(GO:0001848) |
2.8 | 5.7 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
2.8 | 8.5 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
2.8 | 30.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
2.8 | 5.6 | GO:0030911 | TPR domain binding(GO:0030911) |
2.8 | 14.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
2.8 | 27.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
2.8 | 5.6 | GO:0019961 | interferon binding(GO:0019961) |
2.8 | 22.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
2.8 | 5.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
2.8 | 30.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
2.7 | 8.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
2.7 | 51.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
2.7 | 24.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
2.7 | 10.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
2.7 | 18.9 | GO:0035197 | siRNA binding(GO:0035197) |
2.7 | 8.1 | GO:0051425 | PTB domain binding(GO:0051425) |
2.7 | 24.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
2.7 | 2.7 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
2.7 | 2.7 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
2.6 | 13.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
2.6 | 18.4 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
2.6 | 7.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
2.6 | 5.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
2.6 | 10.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
2.6 | 18.0 | GO:0046790 | virion binding(GO:0046790) |
2.6 | 12.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
2.6 | 12.8 | GO:0043426 | MRF binding(GO:0043426) |
2.5 | 10.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
2.5 | 7.6 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
2.5 | 5.1 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
2.5 | 10.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.5 | 7.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
2.5 | 35.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
2.5 | 17.5 | GO:0008494 | translation activator activity(GO:0008494) |
2.5 | 2.5 | GO:0034618 | arginine binding(GO:0034618) |
2.5 | 17.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
2.5 | 29.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
2.5 | 36.8 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
2.5 | 19.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.5 | 22.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
2.5 | 2.5 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
2.4 | 7.3 | GO:2001070 | starch binding(GO:2001070) |
2.4 | 39.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
2.4 | 2.4 | GO:0043559 | insulin binding(GO:0043559) |
2.4 | 7.2 | GO:0019767 | IgE receptor activity(GO:0019767) |
2.4 | 12.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
2.4 | 4.8 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
2.4 | 4.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
2.4 | 7.1 | GO:0050693 | LBD domain binding(GO:0050693) |
2.3 | 18.8 | GO:0015250 | water channel activity(GO:0015250) |
2.3 | 41.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
2.3 | 9.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
2.3 | 9.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
2.3 | 16.2 | GO:0031996 | thioesterase binding(GO:0031996) |
2.3 | 27.7 | GO:0030955 | potassium ion binding(GO:0030955) |
2.3 | 2.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
2.3 | 9.2 | GO:0009374 | biotin binding(GO:0009374) |
2.3 | 9.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
2.3 | 25.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
2.3 | 43.5 | GO:0030552 | cAMP binding(GO:0030552) |
2.3 | 18.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
2.3 | 70.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
2.3 | 25.0 | GO:0097602 | cullin family protein binding(GO:0097602) |
2.3 | 27.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
2.3 | 2.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
2.2 | 11.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
2.2 | 102.7 | GO:0043022 | ribosome binding(GO:0043022) |
2.2 | 2.2 | GO:0089720 | caspase binding(GO:0089720) |
2.2 | 13.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
2.2 | 4.4 | GO:0070538 | oleic acid binding(GO:0070538) |
2.2 | 2.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
2.2 | 15.4 | GO:0018655 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
2.2 | 4.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
2.2 | 26.2 | GO:0001618 | virus receptor activity(GO:0001618) |
2.2 | 30.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
2.2 | 6.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
2.2 | 8.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
2.2 | 6.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
2.1 | 4.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
2.1 | 19.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
2.1 | 12.9 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
2.1 | 10.7 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
2.1 | 10.7 | GO:0043495 | protein anchor(GO:0043495) |
2.1 | 4.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
2.1 | 6.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
2.1 | 2.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
2.1 | 6.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
2.1 | 14.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
2.1 | 2.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
2.1 | 6.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
2.1 | 4.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
2.1 | 12.7 | GO:0030274 | LIM domain binding(GO:0030274) |
2.1 | 6.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
2.1 | 6.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
2.1 | 10.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
2.1 | 12.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
2.1 | 8.3 | GO:0036033 | mediator complex binding(GO:0036033) |
2.1 | 16.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
2.1 | 10.4 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
2.1 | 6.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
2.1 | 4.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
2.1 | 6.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
2.1 | 10.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
2.1 | 4.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
2.0 | 18.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
2.0 | 4.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
2.0 | 6.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
2.0 | 4.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
2.0 | 6.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
2.0 | 9.9 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
2.0 | 4.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
2.0 | 9.9 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
2.0 | 54.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.9 | 9.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.9 | 7.8 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.9 | 7.7 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.9 | 5.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
1.9 | 5.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.9 | 21.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.9 | 13.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
1.9 | 7.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.9 | 9.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.9 | 56.9 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
1.9 | 7.6 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.9 | 3.8 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
1.9 | 49.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
1.9 | 52.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
1.9 | 5.6 | GO:0035514 | DNA demethylase activity(GO:0035514) |
1.9 | 7.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.9 | 5.6 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
1.9 | 312.1 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
1.9 | 147.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
1.9 | 18.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.9 | 16.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.9 | 1.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.9 | 27.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.9 | 55.5 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
1.8 | 25.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
1.8 | 11.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
1.8 | 12.8 | GO:0070034 | telomerase RNA binding(GO:0070034) |
1.8 | 51.3 | GO:0042805 | actinin binding(GO:0042805) |
1.8 | 7.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
1.8 | 5.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
1.8 | 1.8 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
1.8 | 1.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.8 | 9.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.8 | 9.0 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
1.8 | 5.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.8 | 114.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
1.8 | 5.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.8 | 5.4 | GO:0002046 | opsin binding(GO:0002046) |
1.8 | 8.9 | GO:0015288 | porin activity(GO:0015288) |
1.8 | 10.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
1.8 | 5.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.8 | 14.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.8 | 8.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.8 | 8.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.7 | 17.5 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
1.7 | 3.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.7 | 3.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
1.7 | 17.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
1.7 | 8.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.7 | 6.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.7 | 10.3 | GO:0050733 | RS domain binding(GO:0050733) |
1.7 | 48.1 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
1.7 | 10.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
1.7 | 3.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.7 | 8.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
1.7 | 13.7 | GO:0070628 | proteasome binding(GO:0070628) |
1.7 | 1.7 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.7 | 1.7 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
1.7 | 5.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.7 | 6.7 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.7 | 26.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
1.7 | 18.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
1.7 | 16.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
1.7 | 5.0 | GO:0005534 | galactose binding(GO:0005534) |
1.7 | 16.6 | GO:0016918 | retinal binding(GO:0016918) |
1.7 | 9.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.6 | 21.4 | GO:0090484 | drug transporter activity(GO:0090484) |
1.6 | 4.9 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
1.6 | 13.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.6 | 18.0 | GO:0032183 | SUMO binding(GO:0032183) |
1.6 | 4.9 | GO:0030621 | U4 snRNA binding(GO:0030621) |
1.6 | 3.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
1.6 | 27.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.6 | 21.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.6 | 20.9 | GO:0008143 | poly(A) binding(GO:0008143) |
1.6 | 14.5 | GO:0005123 | death receptor binding(GO:0005123) |
1.6 | 9.6 | GO:0050700 | CARD domain binding(GO:0050700) |
1.6 | 1.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.6 | 4.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.6 | 4.8 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
1.6 | 12.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.6 | 4.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.6 | 6.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.6 | 4.8 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.6 | 3.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.6 | 7.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.6 | 20.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.6 | 9.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.6 | 3.1 | GO:0051373 | FATZ binding(GO:0051373) |
1.6 | 6.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.6 | 4.7 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.6 | 3.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
1.5 | 3.1 | GO:1990188 | euchromatin binding(GO:1990188) |
1.5 | 1.5 | GO:0019863 | IgE binding(GO:0019863) |
1.5 | 12.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.5 | 3.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
1.5 | 1.5 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
1.5 | 1.5 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.5 | 6.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.5 | 1.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
1.5 | 1.5 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.5 | 9.2 | GO:0045545 | syndecan binding(GO:0045545) |
1.5 | 3.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.5 | 9.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.5 | 1.5 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
1.5 | 4.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.5 | 4.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.5 | 4.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.5 | 10.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.5 | 1.5 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
1.5 | 22.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
1.5 | 5.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.5 | 1.5 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
1.5 | 19.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.5 | 16.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
1.5 | 122.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
1.5 | 11.6 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
1.5 | 5.8 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
1.4 | 7.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.4 | 34.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.4 | 2.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.4 | 5.8 | GO:0048156 | tau protein binding(GO:0048156) |
1.4 | 2.9 | GO:0008147 | structural constituent of bone(GO:0008147) |
1.4 | 7.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.4 | 2.8 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
1.4 | 11.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.4 | 4.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.4 | 15.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.4 | 8.4 | GO:0052850 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
1.4 | 40.6 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
1.4 | 21.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.4 | 2.8 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
1.4 | 11.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
1.4 | 8.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
1.4 | 5.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.4 | 8.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.4 | 13.8 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
1.4 | 38.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
1.4 | 12.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
1.4 | 26.2 | GO:0030515 | snoRNA binding(GO:0030515) |
1.4 | 4.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.4 | 2.8 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
1.4 | 4.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.4 | 4.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.4 | 8.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
1.4 | 2.7 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
1.4 | 1.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.4 | 27.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.4 | 2.7 | GO:0000182 | rDNA binding(GO:0000182) |
1.4 | 61.2 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
1.4 | 55.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
1.4 | 52.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
1.3 | 4.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.3 | 5.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.3 | 22.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
1.3 | 54.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.3 | 13.3 | GO:0052714 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.3 | 13.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.3 | 6.6 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
1.3 | 2.6 | GO:0008252 | nucleotidase activity(GO:0008252) |
1.3 | 17.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.3 | 44.7 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
1.3 | 35.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
1.3 | 6.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.3 | 3.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.3 | 35.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
1.3 | 5.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.3 | 69.8 | GO:0051087 | chaperone binding(GO:0051087) |
1.3 | 3.9 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
1.3 | 6.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.3 | 3.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.3 | 6.3 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
1.3 | 2.5 | GO:2001069 | glycogen binding(GO:2001069) |
1.3 | 11.4 | GO:0031491 | nucleosome binding(GO:0031491) |
1.3 | 1.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.3 | 5.0 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
1.3 | 8.8 | GO:0001221 | transcription cofactor binding(GO:0001221) |
1.2 | 5.0 | GO:0048495 | Roundabout binding(GO:0048495) |
1.2 | 14.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.2 | 11.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
1.2 | 58.1 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
1.2 | 3.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
1.2 | 13.5 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
1.2 | 3.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
1.2 | 81.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
1.2 | 12.2 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
1.2 | 3.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.2 | 32.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
1.2 | 12.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.2 | 14.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.2 | 3.6 | GO:0043199 | sulfate binding(GO:0043199) |
1.2 | 18.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
1.2 | 3.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.2 | 10.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
1.2 | 9.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.2 | 9.6 | GO:0015266 | protein channel activity(GO:0015266) |
1.2 | 2.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.2 | 15.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
1.2 | 5.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.2 | 2.4 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
1.2 | 4.7 | GO:0042731 | PH domain binding(GO:0042731) |
1.2 | 17.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.2 | 3.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.2 | 37.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
1.2 | 4.7 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.2 | 1.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.2 | 4.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
1.2 | 69.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
1.2 | 4.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
1.2 | 3.5 | GO:0019976 | interleukin-2 binding(GO:0019976) |
1.2 | 10.4 | GO:0004568 | chitinase activity(GO:0004568) |
1.2 | 123.9 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
1.2 | 16.1 | GO:0008483 | transaminase activity(GO:0008483) |
1.2 | 1.2 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.2 | 3.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
1.1 | 14.9 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
1.1 | 4.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.1 | 2.3 | GO:0008142 | oxysterol binding(GO:0008142) |
1.1 | 17.1 | GO:0005537 | mannose binding(GO:0005537) |
1.1 | 14.8 | GO:0045502 | dynein binding(GO:0045502) |
1.1 | 8.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.1 | 3.4 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
1.1 | 24.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
1.1 | 5.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
1.1 | 3.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.1 | 1.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.1 | 7.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
1.1 | 52.5 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
1.1 | 3.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.1 | 1.1 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
1.1 | 1.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.1 | 8.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
1.1 | 10.0 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) potassium ion antiporter activity(GO:0022821) |
1.1 | 7.8 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
1.1 | 14.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
1.1 | 6.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.1 | 1.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.1 | 1.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.1 | 1.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
1.1 | 2.2 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
1.1 | 1.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
1.1 | 3.2 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.1 | 4.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.1 | 3.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
1.1 | 2.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.1 | 2.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.1 | 8.6 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
1.1 | 13.9 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
1.1 | 8.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
1.1 | 30.7 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
1.1 | 5.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.0 | 1.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
1.0 | 2.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.0 | 5.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
1.0 | 34.4 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
1.0 | 2.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
1.0 | 2.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
1.0 | 8.3 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
1.0 | 4.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
1.0 | 30.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
1.0 | 1.0 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
1.0 | 5.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
1.0 | 2.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.0 | 2.0 | GO:0031433 | telethonin binding(GO:0031433) |
1.0 | 2.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.0 | 22.1 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
1.0 | 4.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.0 | 3.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.0 | 5.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.0 | 1.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.0 | 6.0 | GO:0010181 | FMN binding(GO:0010181) |
1.0 | 4.0 | GO:0019966 | interleukin-1 binding(GO:0019966) |
1.0 | 4.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
1.0 | 5.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.0 | 46.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
1.0 | 3.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.0 | 25.6 | GO:0030674 | protein binding, bridging(GO:0030674) |
1.0 | 2.0 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
1.0 | 4.9 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.0 | 4.9 | GO:0005499 | vitamin D binding(GO:0005499) |
1.0 | 14.6 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
1.0 | 3.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
1.0 | 8.7 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
1.0 | 4.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
1.0 | 7.7 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
1.0 | 3.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
1.0 | 93.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
1.0 | 11.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
1.0 | 5.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.0 | 3.8 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
1.0 | 6.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.0 | 1.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.0 | 1.9 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.9 | 2.8 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.9 | 18.0 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.9 | 11.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.9 | 4.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.9 | 2.8 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.9 | 6.6 | GO:0030371 | translation repressor activity(GO:0030371) |
0.9 | 8.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.9 | 2.8 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.9 | 1.9 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.9 | 9.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.9 | 40.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.9 | 5.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.9 | 2.8 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.9 | 12.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.9 | 1.8 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.9 | 0.9 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.9 | 6.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.9 | 11.9 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.9 | 3.6 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.9 | 8.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.9 | 1.8 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.9 | 2.7 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.9 | 31.6 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.9 | 3.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.9 | 1.8 | GO:0019862 | IgA binding(GO:0019862) |
0.9 | 1.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.9 | 3.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.9 | 32.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.9 | 9.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.9 | 3.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.9 | 1.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.9 | 8.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.9 | 35.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.9 | 1.7 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.9 | 3.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.9 | 9.4 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.9 | 2.6 | GO:0031432 | titin binding(GO:0031432) |
0.9 | 3.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.9 | 31.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.8 | 9.3 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.8 | 10.1 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.8 | 1.7 | GO:0038132 | neuregulin binding(GO:0038132) |
0.8 | 1.7 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.8 | 10.0 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.8 | 3.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.8 | 1.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.8 | 4.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.8 | 13.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.8 | 57.0 | GO:0000149 | SNARE binding(GO:0000149) |
0.8 | 0.8 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.8 | 0.8 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.8 | 3.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.8 | 3.2 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.8 | 2.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.8 | 28.0 | GO:0016791 | phosphatase activity(GO:0016791) |
0.8 | 1.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.8 | 8.7 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.8 | 5.6 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.8 | 2.4 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.8 | 0.8 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.8 | 2.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.8 | 3.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.8 | 3.9 | GO:0005522 | profilin binding(GO:0005522) |
0.8 | 0.8 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.8 | 5.3 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.8 | 10.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.8 | 7.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.8 | 6.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.8 | 4.5 | GO:0031386 | protein tag(GO:0031386) |
0.7 | 3.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.7 | 0.7 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.7 | 5.2 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.7 | 3.7 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.7 | 29.4 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.7 | 15.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.7 | 2.9 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.7 | 2.2 | GO:0019213 | deacetylase activity(GO:0019213) |
0.7 | 7.2 | GO:0004518 | nuclease activity(GO:0004518) |
0.7 | 2.9 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.7 | 2.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.7 | 9.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.7 | 0.7 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.7 | 40.5 | GO:0004519 | endonuclease activity(GO:0004519) |
0.7 | 3.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.7 | 3.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.7 | 15.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.7 | 23.4 | GO:0019209 | kinase activator activity(GO:0019209) |
0.7 | 3.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.7 | 3.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.7 | 1.4 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.7 | 0.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.7 | 1.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.7 | 120.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.7 | 1.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.7 | 2.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.7 | 4.8 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.7 | 0.7 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.7 | 20.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.7 | 11.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.7 | 8.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.7 | 2.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.7 | 0.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.7 | 1.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.7 | 1.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.7 | 3.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.7 | 25.7 | GO:0051020 | GTPase binding(GO:0051020) |
0.7 | 4.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.6 | 0.6 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.6 | 10.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.6 | 1.9 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.6 | 28.5 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.6 | 46.5 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.6 | 0.6 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.6 | 3.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.6 | 0.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.6 | 12.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.6 | 11.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.6 | 3.1 | GO:0048038 | quinone binding(GO:0048038) |
0.6 | 18.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.6 | 1.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.6 | 5.5 | GO:0008236 | serine-type peptidase activity(GO:0008236) serine hydrolase activity(GO:0017171) |
0.6 | 4.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.6 | 3.0 | GO:0036122 | BMP binding(GO:0036122) |
0.6 | 1.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.6 | 1.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.6 | 1.8 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.6 | 1.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.6 | 1.7 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.6 | 14.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.6 | 1.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.6 | 2.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.6 | 1.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.6 | 1.7 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.6 | 5.7 | GO:0000049 | tRNA binding(GO:0000049) |
0.6 | 1.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.6 | 2.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.6 | 5.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.6 | 29.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.6 | 2.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.6 | 9.5 | GO:0005507 | copper ion binding(GO:0005507) |
0.6 | 1.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.6 | 4.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.6 | 2.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.6 | 3.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.5 | 1.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.5 | 7.5 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.5 | 4.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.5 | 26.7 | GO:0005506 | iron ion binding(GO:0005506) |
0.5 | 15.6 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.5 | 4.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.5 | 1.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.5 | 11.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.5 | 2.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.5 | 6.5 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.5 | 0.5 | GO:0032190 | acrosin binding(GO:0032190) |
0.5 | 9.4 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.5 | 24.2 | GO:0044325 | ion channel binding(GO:0044325) |
0.5 | 1.5 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.5 | 2.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.5 | 1.5 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 1.0 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.5 | 49.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.5 | 7.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.5 | 2.9 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.5 | 2.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.5 | 41.4 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.5 | 0.5 | GO:0031014 | troponin T binding(GO:0031014) |
0.5 | 6.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.5 | 2.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 102.7 | GO:0005525 | GTP binding(GO:0005525) |
0.5 | 1.4 | GO:0070513 | death domain binding(GO:0070513) |
0.5 | 10.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.5 | 0.5 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.5 | 0.9 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 1.8 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.4 | 15.1 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.4 | 5.3 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.4 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.4 | 15.7 | GO:0001047 | core promoter binding(GO:0001047) |
0.4 | 1.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.4 | 0.4 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.4 | 1.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 0.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.4 | 1.3 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.4 | 2.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.4 | 2.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.4 | 0.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 1.2 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.4 | 83.4 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.4 | 0.4 | GO:0051870 | methotrexate binding(GO:0051870) |
0.4 | 4.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 2.8 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.4 | 4.0 | GO:0043236 | laminin binding(GO:0043236) |
0.4 | 0.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 12.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.4 | 0.4 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.4 | 44.0 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.4 | 25.3 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.4 | 0.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.4 | 0.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.4 | 5.3 | GO:0002039 | p53 binding(GO:0002039) |
0.4 | 1.9 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.4 | 8.0 | GO:0043621 | protein self-association(GO:0043621) |
0.4 | 8.4 | GO:0020037 | heme binding(GO:0020037) |
0.4 | 1.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.4 | 1.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.4 | 1.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.4 | 1.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.4 | 2.2 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.3 | 2.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 3.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 1.4 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.3 | 30.5 | GO:0005550 | pheromone binding(GO:0005550) |
0.3 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 3.7 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.3 | 0.7 | GO:1990405 | protein antigen binding(GO:1990405) |
0.3 | 1.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 186.0 | GO:0003723 | RNA binding(GO:0003723) |
0.3 | 1.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.3 | 0.9 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 1.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.3 | 3.1 | GO:0002020 | protease binding(GO:0002020) |
0.3 | 2.5 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.3 | 5.3 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.3 | 0.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 1.9 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.3 | 1.6 | GO:0019955 | cytokine binding(GO:0019955) |
0.3 | 1.3 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.3 | 3.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 1.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.3 | 0.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 7.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.3 | 1.0 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.3 | 4.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 1.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.7 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.2 | 0.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 6.7 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.2 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 6.4 | GO:0016887 | ATPase activity(GO:0016887) |
0.2 | 1.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.4 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.2 | 0.2 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.2 | 0.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.2 | 2.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.2 | 4.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 0.6 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.2 | 3.2 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.2 | 0.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 0.6 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.2 | 0.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 2.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 0.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 192.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.2 | 1.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 0.2 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 3.2 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.2 | 0.5 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.2 | 4.5 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 2.0 | GO:0008144 | drug binding(GO:0008144) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 23.2 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.1 | 0.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.8 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.1 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 0.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 3.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 3.7 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.6 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 1.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.6 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 2.3 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.5 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.1 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 14.9 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.1 | 2.4 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 1.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 2.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 1.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 1.0 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 0.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 3.0 | GO:0005126 | cytokine receptor binding(GO:0005126) |
0.1 | 0.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.8 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.0 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 78.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
4.8 | 144.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
4.5 | 45.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
4.2 | 144.3 | PID RHOA PATHWAY | RhoA signaling pathway |
4.0 | 124.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
3.9 | 54.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
3.7 | 3.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
3.6 | 36.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
3.5 | 3.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
3.5 | 10.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
3.2 | 6.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
3.2 | 9.6 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
3.0 | 47.6 | PID ARF 3PATHWAY | Arf1 pathway |
2.9 | 120.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
2.8 | 22.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
2.7 | 137.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
2.6 | 15.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
2.5 | 56.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
2.5 | 45.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
2.5 | 100.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
2.5 | 19.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
2.4 | 41.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
2.4 | 46.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
2.4 | 16.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
2.4 | 16.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
2.3 | 14.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
2.3 | 38.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.2 | 33.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
2.2 | 115.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
2.2 | 37.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
2.2 | 21.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
2.1 | 32.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
2.1 | 68.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
2.1 | 10.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
2.1 | 8.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
2.1 | 29.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
2.1 | 116.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
2.1 | 44.3 | PID ATM PATHWAY | ATM pathway |
2.1 | 45.4 | PID BARD1 PATHWAY | BARD1 signaling events |
2.0 | 14.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.9 | 25.3 | PID IFNG PATHWAY | IFN-gamma pathway |
1.9 | 46.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.9 | 74.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
1.8 | 12.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.8 | 40.6 | PID AURORA A PATHWAY | Aurora A signaling |
1.8 | 54.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
1.8 | 30.6 | PID INSULIN PATHWAY | Insulin Pathway |
1.8 | 8.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.8 | 31.8 | PID FOXO PATHWAY | FoxO family signaling |
1.8 | 40.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
1.7 | 24.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
1.7 | 36.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
1.7 | 22.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.7 | 35.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
1.7 | 27.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.7 | 28.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.7 | 8.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
1.6 | 9.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.6 | 38.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.5 | 58.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.5 | 4.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.4 | 19.6 | PID MYC PATHWAY | C-MYC pathway |
1.3 | 36.1 | PID PLK1 PATHWAY | PLK1 signaling events |
1.3 | 19.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.3 | 8.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.3 | 15.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
1.3 | 3.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
1.3 | 10.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
1.3 | 12.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.2 | 11.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
1.2 | 3.7 | PID SHP2 PATHWAY | SHP2 signaling |
1.2 | 7.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
1.2 | 19.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.2 | 17.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
1.2 | 21.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.2 | 4.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.2 | 11.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.2 | 23.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
1.2 | 18.4 | PID ATR PATHWAY | ATR signaling pathway |
1.1 | 2.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.1 | 12.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.1 | 5.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.1 | 31.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
1.1 | 8.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
1.0 | 71.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
1.0 | 14.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
1.0 | 2.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.0 | 1.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
1.0 | 5.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
1.0 | 21.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.0 | 18.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.9 | 14.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.9 | 30.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.9 | 9.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.9 | 0.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.9 | 9.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.9 | 4.5 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.9 | 8.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.9 | 21.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.9 | 9.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.9 | 9.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.8 | 2.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.8 | 8.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.8 | 11.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.8 | 0.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.8 | 1.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.8 | 1.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.8 | 6.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.8 | 7.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.8 | 0.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.8 | 3.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.8 | 2.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.8 | 7.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.7 | 13.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.7 | 5.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.7 | 1.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.7 | 5.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.6 | 1.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.6 | 2.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.6 | 18.0 | PID BMP PATHWAY | BMP receptor signaling |
0.6 | 5.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.6 | 10.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.6 | 2.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.5 | 2.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.5 | 2.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 5.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 11.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.5 | 4.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.5 | 1.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.5 | 4.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.5 | 1.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.5 | 9.2 | PID E2F PATHWAY | E2F transcription factor network |
0.5 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.5 | 5.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 3.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.4 | 4.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.4 | 1.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.4 | 2.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.4 | 68.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 0.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 1.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 2.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 0.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.3 | 1.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 1.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 1.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 6.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 2.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 23.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 1.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 1.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 1.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 0.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 1.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 5.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.5 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 9.2 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.0 | 182.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
7.7 | 92.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
7.4 | 14.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
6.5 | 13.0 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
6.4 | 64.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
6.3 | 63.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
5.8 | 40.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
5.5 | 49.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
5.5 | 60.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
5.4 | 54.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
5.0 | 69.6 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
4.9 | 63.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
4.9 | 9.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
4.7 | 70.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
4.7 | 41.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
4.6 | 111.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
4.6 | 36.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
4.5 | 40.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
4.5 | 120.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
4.3 | 108.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
4.1 | 45.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
4.1 | 4.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
4.1 | 12.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
3.8 | 49.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
3.8 | 42.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
3.8 | 45.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
3.7 | 36.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
3.3 | 78.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
3.2 | 87.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
3.2 | 6.4 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
3.2 | 22.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
3.2 | 57.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
3.1 | 84.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
3.1 | 24.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
3.1 | 133.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
2.9 | 29.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
2.9 | 5.8 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
2.9 | 48.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
2.8 | 28.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
2.8 | 19.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
2.8 | 5.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
2.8 | 11.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
2.7 | 128.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
2.7 | 16.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
2.7 | 48.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
2.7 | 53.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
2.7 | 8.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
2.7 | 5.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
2.6 | 28.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.6 | 20.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
2.6 | 54.2 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
2.5 | 45.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
2.5 | 7.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
2.5 | 5.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
2.4 | 12.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
2.4 | 14.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
2.4 | 38.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
2.4 | 30.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
2.4 | 4.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
2.3 | 2.3 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
2.3 | 18.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
2.3 | 36.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
2.3 | 20.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
2.3 | 2.3 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
2.3 | 22.7 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
2.3 | 6.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
2.2 | 2.2 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
2.2 | 67.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
2.2 | 79.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
2.2 | 13.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
2.2 | 2.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
2.2 | 23.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
2.1 | 2.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
2.1 | 98.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
2.1 | 40.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
2.1 | 33.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
2.1 | 49.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
2.0 | 76.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
2.0 | 30.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
2.0 | 8.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
2.0 | 8.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
2.0 | 19.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
2.0 | 35.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
2.0 | 35.5 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
2.0 | 27.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
2.0 | 11.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.9 | 44.8 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
1.9 | 11.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.9 | 11.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.9 | 9.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.9 | 38.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
1.9 | 20.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.9 | 41.0 | REACTOME KINESINS | Genes involved in Kinesins |
1.8 | 9.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.8 | 18.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.8 | 7.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.8 | 27.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.8 | 10.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.8 | 41.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
1.8 | 21.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
1.8 | 28.7 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
1.8 | 19.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.8 | 15.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.7 | 12.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.7 | 84.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.7 | 43.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
1.7 | 63.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
1.7 | 6.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
1.6 | 6.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.6 | 16.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.6 | 1.6 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.6 | 41.7 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
1.6 | 8.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
1.6 | 4.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
1.6 | 34.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.6 | 15.6 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
1.5 | 24.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.5 | 54.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
1.5 | 7.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.5 | 7.6 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
1.5 | 7.6 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
1.5 | 10.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
1.5 | 4.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.5 | 25.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.4 | 34.6 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
1.4 | 42.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.4 | 14.0 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
1.4 | 22.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
1.4 | 14.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.3 | 14.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.3 | 6.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
1.3 | 117.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
1.3 | 34.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
1.2 | 4.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
1.2 | 9.9 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
1.2 | 18.3 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
1.2 | 12.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.2 | 9.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.2 | 12.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.2 | 8.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.2 | 26.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
1.2 | 20.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.2 | 1.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
1.2 | 2.4 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
1.2 | 9.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
1.2 | 9.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
1.2 | 5.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.2 | 14.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.2 | 5.8 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.1 | 143.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
1.1 | 3.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.1 | 9.1 | REACTOME OPSINS | Genes involved in Opsins |
1.1 | 2.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.1 | 15.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.1 | 21.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.1 | 18.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
1.1 | 8.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
1.1 | 14.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
1.1 | 13.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
1.1 | 1.1 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
1.1 | 9.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.0 | 83.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
1.0 | 11.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
1.0 | 5.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.0 | 14.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
1.0 | 21.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
1.0 | 71.3 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
1.0 | 14.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
1.0 | 3.9 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
1.0 | 17.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.9 | 3.7 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.9 | 110.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.9 | 21.3 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.9 | 16.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.9 | 15.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.9 | 36.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.9 | 1.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.9 | 25.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.9 | 1.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.9 | 4.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.9 | 6.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.8 | 2.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.8 | 13.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.8 | 14.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.8 | 9.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.8 | 3.3 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.8 | 9.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.8 | 4.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.8 | 12.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.8 | 4.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.8 | 6.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.8 | 7.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.7 | 8.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.7 | 28.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.7 | 44.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.7 | 12.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.7 | 4.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.7 | 15.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.6 | 7.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.6 | 3.8 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.6 | 4.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.6 | 10.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.6 | 10.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.6 | 11.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.6 | 10.7 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.6 | 1.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.6 | 10.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.5 | 8.8 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.5 | 6.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.5 | 1.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.5 | 3.8 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.5 | 2.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.5 | 11.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.5 | 1.6 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.5 | 3.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.5 | 2.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.5 | 15.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.5 | 5.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 5.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.5 | 7.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.5 | 1.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.5 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.4 | 1.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.4 | 6.4 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.4 | 23.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.4 | 3.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.4 | 45.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.4 | 2.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.4 | 20.3 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.4 | 3.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 8.1 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.4 | 6.7 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.4 | 1.1 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.3 | 6.9 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.3 | 1.7 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.3 | 12.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 2.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 2.8 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.3 | 0.3 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.3 | 1.4 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.3 | 2.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 0.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 1.0 | REACTOME DEFENSINS | Genes involved in Defensins |
0.2 | 0.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 0.6 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.2 | 2.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 0.7 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.2 | 0.5 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.9 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.5 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.1 | 2.8 | REACTOME CELL CYCLE | Genes involved in Cell Cycle |
0.1 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 2.6 | REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT | Genes involved in SLC-mediated transmembrane transport |
0.0 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |